| 1 |
Expression and modulation of annexin VIII in human leukemia-lymphoma cell lines.Leuk Res. 1993 Nov;17(11):949-57. doi: 10.1016/0145-2126(93)90042-j.
|
| 2 |
Mitochondrial hypoxic stress induces widespread RNA editing by APOBEC3G in natural killer cells.Genome Biol. 2019 Feb 21;20(1):37. doi: 10.1186/s13059-019-1651-1.
|
| 3 |
Molecular cloning, structural modeling and production of recombinant Aspergillus terreusl. asparaginase in Escherichia coli.Int J Biol Macromol. 2018 Jan;106:1041-1051. doi: 10.1016/j.ijbiomac.2017.08.110. Epub 2017 Aug 26.
|
| 4 |
Tumor suppressors BTG1 and BTG2: Beyond growth control.J Cell Physiol. 2019 May;234(5):5379-5389. doi: 10.1002/jcp.27407. Epub 2018 Oct 23.
|
| 5 |
hBUB1 defects in leukemia and lymphoma cells.Oncogene. 2002 Jul 11;21(30):4673-9. doi: 10.1038/sj.onc.1205585.
|
| 6 |
Frameshift mutations in caspase-5 and other target genes in leukemia and lymphoma cell lines having microsatellite instability.Leuk Res. 2003 Apr;27(4):359-61. doi: 10.1016/s0145-2126(02)00215-1.
|
| 7 |
Development of specific nanobodies (VHH) for CD19 immuno-targeting of human B-lymphocytes.Iran J Basic Med Sci. 2018 May;21(5):455-464. doi: 10.22038/IJBMS.2018.26778.6557.
|
| 8 |
Distinct breakpoints in band 11q23 of the t(4;11) and t(11;14) associated with leukocyte malignancy.Genes Chromosomes Cancer. 1992 Jul;5(1):50-6. doi: 10.1002/gcc.2870050108.
|
| 9 |
cdc25 cell cycle-activating phosphatases and c-myc expression in human non-Hodgkin's lymphomas.Cancer Res. 1998 Apr 15;58(8):1762-7.
|
| 10 |
Expression of cholesteryl ester transfer protein (CETP) in germinal centre B cells and their neoplastic counterparts.Histopathology. 2004 Jul;45(1):73-81. doi: 10.1111/j.1365-2559.2004.01905.x.
|
| 11 |
Biomarker Dynamics in B-cell Lymphoma: A Longitudinal Prospective Study of Plasma Samples Up to 25 Years before Diagnosis.Cancer Res. 2017 Mar 15;77(6):1408-1415. doi: 10.1158/0008-5472.CAN-16-2345. Epub 2017 Jan 20.
|
| 12 |
Alterations of the cyclin-dependent kinase inhibitor p19 (INK4D) is rare in hematopoietic malignancies.Leukemia. 1996 Dec;10(12):1897-900.
|
| 13 |
Epstein-Barr virus-related lymphomagenesis in a child with Wiskott-Aldrich syndrome.Hematol Oncol. 1993 May-Jun;11(3):139-45. doi: 10.1002/hon.2900110304.
|
| 14 |
Expression of truncated transcripts of the proto-oncogene c-fps/fes in human lymphoma and lymphoid leukemia cell lines.Oncogene. 1992 May;7(5):943-52.
|
| 15 |
Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells.J Biol Chem. 1995 Jan 13;270(2):815-22. doi: 10.1074/jbc.270.2.815.
|
| 16 |
Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin.Hum Pathol. 2000 Feb;31(2):263-8. doi: 10.1016/s0046-8177(00)80233-6.
|
| 17 |
Medical conditions in Ashkenazi schizophrenic pedigrees.Schizophr Bull. 1994;20(3):507-17. doi: 10.1093/schbul/20.3.507.
|
| 18 |
Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: Lessons from genetic diseases.Immunol Rev. 2019 Sep;291(1):174-189. doi: 10.1111/imr.12791.
|
| 19 |
A case of lymphoblastoid natural killer (NK)-cell lymphoma: association with the NK-cell receptor complex CD94/NKG2 and TP53 intragenic deletion.Br J Dermatol. 2002 Jan;146(1):148-53. doi: 10.1046/j.0007-0963.2001.04571.x.
|
| 20 |
Localization of a lymphocyte-specific protein tyrosine kinase gene (lck) at a site of frequent chromosomal abnormalities in human lymphomas.Proc Natl Acad Sci U S A. 1986 Oct;83(19):7400-4. doi: 10.1073/pnas.83.19.7400.
|
| 21 |
The p54 cleaved form of the tyrosine kinase Lyn generated by caspases during BCR-induced cell death in B lymphoma acts as a negative regulator of apoptosis.FASEB J. 2003 Apr;17(6):711-3. doi: 10.1096/fj.02-0716fje. Epub 2003 Feb 5.
|
| 22 |
Mutations in the mitotic check point gene, MAD1L1, in human cancers.Oncogene. 2001 May 31;20(25):3301-5. doi: 10.1038/sj.onc.1204421.
|
| 23 |
Cloning and expression of a murine cDNA homologous to the human RCK/P54, a lymphoma-linked chromosomal translocation junction gene on 11q23.Gene. 1995 Dec 12;166(2):293-6. doi: 10.1016/0378-1119(95)00559-5.
|
| 24 |
Expression of thrombopoietin and thrombopoietin receptor MPL in human leukemia-lymphoma and solid tumor cell lines.Leuk Res. 1996 Oct;20(10):831-8. doi: 10.1016/s0145-2126(96)00057-4.
|
| 25 |
MM-1, a c-Myc-binding protein, is a candidate for a tumor suppressor in leukemia/lymphoma and tongue cancer.J Biol Chem. 2001 Nov 30;276(48):45137-44. doi: 10.1074/jbc.M106127200. Epub 2001 Sep 20.
|
| 26 |
CRL4(DCAF2) negatively regulates IL-23 production in dendritic cells and limits the development of psoriasis.J Exp Med. 2018 Aug 6;215(8):1999-2017. doi: 10.1084/jem.20180210. Epub 2018 Jul 17.
|
| 27 |
Transcriptional regulatory effects of lymphoma-associated NFKB2/lyt10 protooncogenes.Oncogene. 2000 Mar 2;19(10):1334-45. doi: 10.1038/sj.onc.1203432.
|
| 28 |
Prolactin and the immune system.Immunomethods. 1994 Aug;5(1):21-30. doi: 10.1006/immu.1994.1034.
|
| 29 |
Rearrangement of the T-cell receptor delta chain gene in T-cell lymphomas with a mature phenotype.Am J Pathol. 1991 Jul;139(1):161-8.
|
| 30 |
Chemoattractant receptor-homologous molecule expressed on Th2 cells activation in vivo increases blood leukocyte counts and its blockade abrogates 13,14-dihydro-15-keto-prostaglandin D2-induced eosinophilia in rats.J Pharmacol Exp Ther. 2003 Nov;307(2):518-25. doi: 10.1124/jpet.103.055442. Epub 2003 Sep 15.
|
| 31 |
Kaposi Sarcoma in Association With an Extracavitary Primary Effusion Lymphoma Showing Unusual Intravascular Involvement: Report of a Case Harboring a FAM175A Germline Mutation.Am J Dermatopathol. 2020 Jan;42(1):55-60. doi: 10.1097/DAD.0000000000001491.
|
| 32 |
ROR1 associates unfavorable prognosis and promotes lymphoma growth in DLBCL by affecting PI3K/Akt/mTOR signaling pathway.Biofactors. 2019 May;45(3):416-426. doi: 10.1002/biof.1498. Epub 2019 Feb 24.
|
| 33 |
Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13).Nat Biotechnol. 2000 Nov;18(11):1185-90. doi: 10.1038/81183.
|
| 34 |
Angioedema due to acquired C1-inhibitor deficiency: spectrum and treatment with C1-inhibitor concentrate.Orphanet J Rare Dis. 2019 Mar 13;14(1):65. doi: 10.1186/s13023-019-1043-3.
|
| 35 |
Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma.Haematologica. 2017 Jul;102(7):1247-1257. doi: 10.3324/haematol.2016.163030. Epub 2017 Apr 6.
|
| 36 |
Chemical evaluation and cytotoxic mechanism investigation of Clinacanthus nutans extract in lymphoma SUP-T1 cells.Environ Toxicol. 2018 Dec;33(12):1229-1236. doi: 10.1002/tox.22629. Epub 2018 Sep 6.
|
| 37 |
Pulmonary malignant lymphoma of mucosa-associated lymphoid tissue (MALT) arising in a pediatric HIV-positive patient.Am J Surg Pathol. 1995 Mar;19(3):357-63. doi: 10.1097/00000478-199503000-00014.
|
| 38 |
Stabilin-1 is expressed in human breast cancer and supports tumor growth in mammary adenocarcinoma mouse model. Oncotarget. 2016 May 24;7(21):31097-110.
|
| 39 |
A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells.Leukemia. 2017 Jul;31(7):1611-1621. doi: 10.1038/leu.2016.352. Epub 2017 Nov 28.
|
| 40 |
Effective Targeting of Multiple B-Cell Maturation Antigen-Expressing Hematological Malignances by Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T Cells.Hum Gene Ther. 2018 May;29(5):585-601. doi: 10.1089/hum.2018.001.
|
| 41 |
Systemic lupus erythematosus and lymphoma: Incidence, pathogenesis and biology.Leuk Res. 2018 Dec;75:45-49. doi: 10.1016/j.leukres.2018.11.004. Epub 2018 Nov 12.
|
| 42 |
Truncated TSG101 transcripts in human leukemia and lymphoma cell lines.J Cancer Res Clin Oncol. 2000 Feb;126(2):79-84.
|
| 43 |
Study of the efficacy of a pronucleotide of 2-chloro-2'-deoxyadenosine in deoxycytidine kinase-deficient lymphoma cells.Nucleosides Nucleotides Nucleic Acids. 2006;25(9-11):997-1000. doi: 10.1080/15257770600889444.
|
| 44 |
Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expression.Oncogene. 2006 Feb 9;25(6):888-98. doi: 10.1038/sj.onc.1209127.
|
| 45 |
CTLA4 Promotes Tyk2-STAT3-Dependent B-cell Oncogenicity.Cancer Res. 2017 Sep 15;77(18):5118-5128. doi: 10.1158/0008-5472.CAN-16-0342. Epub 2017 Jul 17.
|
| 46 |
Cutaneous anaplastic large-cell lymphoma should be evaluated for systemic involvement regardless of ALK-1 status: case reports and review of literature.Am J Clin Dermatol. 2011 Jun 1;12(3):203-9. doi: 10.2165/11537520-000000000-00000.
|
| 47 |
High-resolution genomic profiling reveals clonal evolution and competition in gastrointestinal marginal zone B-cell lymphoma and its large cell variant.Int J Cancer. 2013 Feb 1;132(3):E116-27. doi: 10.1002/ijc.27774. Epub 2012 Sep 1.
|
| 48 |
The novel double-hit, t(8;22)(q24;q11)/MYC-IGL and t(14;15)(q32;q24)/IGH-BCL2A1, in diffuse large B-cell lymphoma.Cancer Genet. 2017 Aug;214-215:26-31. doi: 10.1016/j.cancergen.2017.03.009. Epub 2017 Apr 4.
|
| 49 |
Increased T-cell activation and Th1 cytokine concentrations prior to the diagnosis of B-cell lymphoma in HIV infected patients.J Clin Immunol. 2013 Jan;33(1):22-9. doi: 10.1007/s10875-012-9766-0. Epub 2012 Aug 23.
|
| 50 |
Expression and phosphorylation of eukaryotic translation initiation factor 4E binding protein 1 in B-cell lymphomas and reactive lymphoid tissues.Arch Pathol Lab Med. 2011 Mar;135(3):365-71. doi: 10.5858/2009-0759-OA.1.
|
| 51 |
The common viral insertion site Evi12 is located in the 5'-noncoding region of Gnn, a novel gene with enhanced expression in two subclasses of human acute myeloid leukemia.J Virol. 2005 May;79(9):5249-58. doi: 10.1128/JVI.79.9.5249-5258.2005.
|
| 52 |
Joint effect between regular use of non-steroidal anti-inflammatory drugs, variants in inflammatory genes and risk of lymphoma.Cancer Causes Control. 2008 Mar;19(2):163-73. doi: 10.1007/s10552-007-9082-9. Epub 2007 Nov 24.
|
| 53 |
Dual enhancement of T and NK cell function by pulsatile inhibition of SHIP1 improves antitumor immunity and survival.Sci Signal. 2017 Oct 10;10(500):eaam5353. doi: 10.1126/scisignal.aam5353.
|
| 54 |
Identification of Pax5 as a target of MTA1 in B-cell lymphomas.Cancer Res. 2007 Aug 1;67(15):7132-8. doi: 10.1158/0008-5472.CAN-07-0750.
|
| 55 |
Targeting ornithine decarboxylase impairs development of MYCN-amplified neuroblastoma.Cancer Res. 2009 Jan 15;69(2):547-53. doi: 10.1158/0008-5472.CAN-08-2968.
|
| 56 |
Recent Advances in the Function of the 67 kDa Laminin Receptor and its Targeting for Personalized Therapy in Cancer.Curr Pharm Des. 2017;23(32):4745-4757. doi: 10.2174/1381612823666170710125332.
|
| 57 |
HSP70-Hrd1 axis precludes the oncorepressor potential of N-terminal misfolded Blimp-1s in lymphoma cells.Nat Commun. 2017 Aug 25;8(1):363. doi: 10.1038/s41467-017-00476-w.
|
| 58 |
Association of polymorphisms in TRAIL1 and TRAILR1 genes with susceptibility to lymphomas.Ann Hematol. 2014 Feb;93(2):243-7. doi: 10.1007/s00277-013-1864-4.
|
| 59 |
Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells.Cell. 2016 Oct 6;167(2):405-418.e13. doi: 10.1016/j.cell.2016.08.032. Epub 2016 Sep 29.
|
| 60 |
Respiratory uncoupling in skeletal muscle delays death and diminishes age-related disease.Cell Metab. 2007 Dec;6(6):497-505. doi: 10.1016/j.cmet.2007.10.010.
|
| 61 |
Influence of polymorphisms in ERCC5, XPA and MTR DNA repair and synthesis genes in B-cell lymphoma risk. A case-control study in Spanish population.J BUON. 2013 Apr-Jun;18(2):486-90.
|
| 62 |
ZAP-70 enhances B-cell-receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells.Blood. 2007 Mar 1;109(5):2032-9. doi: 10.1182/blood-2006-03-011759. Epub 2006 Oct 12.
|
| 63 |
Phosphatidylinositol 3-kinase blockade increases genomic instability in B cells.Nature. 2017 Feb 23;542(7642):489-493. doi: 10.1038/nature21406. Epub 2017 Feb 15.
|
| 64 |
Inhibitor of Apoptosis (IAP) proteins in hematological malignancies: molecular mechanisms and therapeutic opportunities.Leukemia. 2014 Jul;28(7):1414-22. doi: 10.1038/leu.2014.56. Epub 2014 Feb 3.
|
| 65 |
Analysis of the novel cyclin-dependent kinase 4 and 6 inhibitor gene p18 in lymphoma and leukemia cell lines.Leuk Res. 1996 Feb;20(2):197-200. doi: 10.1016/0145-2126(95)00137-9.
|
| 66 |
Mitotic slippage: an old tale with a new twist.Cell Cycle. 2019 Jan;18(1):7-15. doi: 10.1080/15384101.2018.1559557. Epub 2019 Jan 2.
|
| 67 |
Cutaneous spindled follicle center cell lymphoma with abundant mucin: A diagnostic pitfall.J Cutan Pathol. 2020 Apr;47(4):394-397. doi: 10.1111/cup.13609. Epub 2019 Nov 27.
|
| 68 |
Selective expansion of marginal zone B cells in Emicro-API2-MALT1 mice is linked to enhanced IkappaB kinase gamma polyubiquitination.Cancer Res. 2006 May 15;66(10):5270-7. doi: 10.1158/0008-5472.CAN-05-4590.
|
| 69 |
Systematic Multiomics Analysis of Alterations in C1QBP mRNA Expression and Relevance for Clinical Outcomes in Cancers.J Clin Med. 2019 Apr 15;8(4):513. doi: 10.3390/jcm8040513.
|
| 70 |
Induction of apoptosis in E-myc lymphoma cells in vitro and in vivo through calpain inhibition.Exp Hematol. 2012 Jul;40(7):548-563.e2. doi: 10.1016/j.exphem.2012.02.002. Epub 2012 Feb 23.
|
| 71 |
Challenges of driving CD30-directed CAR-T cells to the clinic.BMC Cancer. 2019 Mar 6;19(1):203. doi: 10.1186/s12885-019-5415-9.
|
| 72 |
Oncogenic role of the chromobox protein CBX7 in gastric cancer.J Exp Clin Cancer Res. 2010 Aug 19;29(1):114. doi: 10.1186/1756-9966-29-114.
|
| 73 |
Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p16INK4A.Leukemia. 2000 May;14(5):898-904. doi: 10.1038/sj.leu.2401761.
|
| 74 |
Early and late hematologic toxicity following CD19 CAR-T cells.Bone Marrow Transplant. 2019 Oct;54(10):1643-1650. doi: 10.1038/s41409-019-0487-3. Epub 2019 Feb 26.
|
| 75 |
During acute graft versus host disease CD28 deletion in donor CD8(+) , but not CD4(+) , Tcells maintain antileukemia responses in mice.Eur J Immunol. 2018 Dec;48(12):2055-2067. doi: 10.1002/eji.201847669. Epub 2018 Nov 14.
|
| 76 |
Development of A Chimeric Antigen Receptor Targeting C-Type Lectin-Like Molecule-1 for Human Acute Myeloid Leukemia.Int J Mol Sci. 2017 Oct 27;18(11):2259. doi: 10.3390/ijms18112259.
|
| 77 |
High frequency of inactivating tetraspanin C D37 mutations in diffuse large B-cell lymphoma at immune-privileged sites.Blood. 2019 Sep 19;134(12):946-950. doi: 10.1182/blood.2019001185. Epub 2019 Jul 31.
|
| 78 |
Augmentation of Saporin-Based Immunotoxins for Human Leukaemia and Lymphoma Cells by Triterpenoid Saponins: The Modifying Effects of Small Molecule Pharmacological Agents.Toxins (Basel). 2019 Feb 20;11(2):127. doi: 10.3390/toxins11020127.
|
| 79 |
RIP1 has a role in CD40-mediated apoptosis in human follicular lymphoma cells.Immunobiology. 2017 Nov;222(11):998-1003. doi: 10.1016/j.imbio.2017.06.001. Epub 2017 Jun 10.
|
| 80 |
CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response.Cancer Cell. 2019 Mar 18;35(3):473-488.e6. doi: 10.1016/j.ccell.2019.02.006.
|
| 81 |
CD47/SIRP blocking enhances CD19/CD3-bispecific T cell engager antibody-mediated lysis of B cell malignancies.Biochem Biophys Res Commun. 2019 Feb 12;509(3):739-745. doi: 10.1016/j.bbrc.2018.12.175. Epub 2019 Jan 3.
|
| 82 |
CD74 interferes with the expression of fas receptor on the surface of lymphoma cells.J Exp Clin Cancer Res. 2014 Oct 10;33(1):80. doi: 10.1186/s13046-014-0080-y.
|
| 83 |
CD79B mutations in primary vitreoretinal lymphoma: Diagnostic and prognostic potential.Eur J Haematol. 2019 Feb;102(2):191-196. doi: 10.1111/ejh.13191. Epub 2018 Nov 23.
|
| 84 |
Evaluation of costimulatory molecules in dogs with B cell high grade lymphoma.PLoS One. 2018 Jul 24;13(7):e0201222. doi: 10.1371/journal.pone.0201222. eCollection 2018.
|
| 85 |
Study on the role of G1 cyclins in Epstein-Barr virus-associated human lymphomas maintained in severe combined immune deficiency (SCID) mice.Int J Cancer. 2001 Apr 15;92(2):232-9. doi: 10.1002/1097-0215(200102)9999:9999<::aid-ijc1171>3.0.co;2-r.
|
| 86 |
Hedyotisdiffusa Willd inhibits proliferation and induces apoptosis of 5FU resistant colorectal cancer cells by regulating the PI3K/AKT signaling pathway.Mol Med Rep. 2018 Jan;17(1):358-365. doi: 10.3892/mmr.2017.7903. Epub 2017 Oct 26.
|
| 87 |
Efficacy of the novel CDK7 inhibitor QS1189 in mantle cell lymphoma.Sci Rep. 2019 May 10;9(1):7193. doi: 10.1038/s41598-019-43760-z.
|
| 88 |
A case-report of a pulmonary tuberculosis with lymphadenopathy mimicking a lymphoma.Int J Infect Dis. 2018 May;70:38-41. doi: 10.1016/j.ijid.2018.02.011. Epub 2018 Mar 1.
|
| 89 |
DNA Damage Response Inhibitor Combinations Exert Synergistic Antitumor Activity in Aggressive B-Cell Lymphomas.Mol Cancer Ther. 2019 Jul;18(7):1255-1264. doi: 10.1158/1535-7163.MCT-18-0919. Epub 2019 May 7.
|
| 90 |
Clinicopathological analysis of 46 cases with CD4(+) and/or CD56(+) immature haematolymphoid malignancy: reappraisal of blastic plasmacytoid dendritic cell and related neoplasms.Histopathology. 2017 Dec;71(6):972-984. doi: 10.1111/his.13340. Epub 2017 Oct 10.
|
| 91 |
Detection of Tax-specific CTLs in lymph nodes of adult T-cell leukemia/lymphoma patients and its association with Foxp3 positivity of regulatory T-cell function.Oncol Lett. 2017 Jun;13(6):4611-4618. doi: 10.3892/ol.2017.6067. Epub 2017 Apr 21.
|
| 92 |
The CREB Coactivator CRTC2 Is a Lymphoma Tumor Suppressor that Preserves Genome Integrity through Transcription of DNA Mismatch Repair Genes.Cell Rep. 2015 Jun 9;11(9):1350-7. doi: 10.1016/j.celrep.2015.04.052. Epub 2015 May 21.
|
| 93 |
CSF1R Protein Expression in Reactive Lymphoid Tissues and Lymphoma: Its Relevance in Classical Hodgkin Lymphoma.PLoS One. 2015 Jun 12;10(6):e0125203. doi: 10.1371/journal.pone.0125203. eCollection 2015.
|
| 94 |
Lentivirus-mediated down-regulation of CK2 inhibits proliferation and induces apoptosis of malignant lymphoma and leukemia cells.Biochem Cell Biol. 2018 Dec;96(6):786-796. doi: 10.1139/bcb-2017-0345. Epub 2018 May 17.
|
| 95 |
Diacylglycerol Kinase Limits Cytokine-dependent Expansion of CD8(+) T Cells with Broad Antitumor Capacity.EBioMedicine. 2017 May;19:39-48. doi: 10.1016/j.ebiom.2017.04.024. Epub 2017 Apr 14.
|
| 96 |
Regulation of EBV LMP1-triggered EphA4 downregulation in EBV-associated B lymphoma and its impact on patients' survival.Blood. 2016 Sep 22;128(12):1578-89. doi: 10.1182/blood-2016-02-702530. Epub 2016 Jun 23.
|
| 97 |
Functional genomics lead to new therapies in follicular lymphoma.Ann N Y Acad Sci. 2013 Jul;1293:18-24. doi: 10.1111/nyas.12120. Epub 2013 May 15.
|
| 98 |
High coagulation factor VIII and von Willebrand factor in patients with lymphoma and leukemia.Int J Hematol. 2016 Feb;103(2):189-95. doi: 10.1007/s12185-015-1913-y. Epub 2015 Nov 26.
|
| 99 |
EBV lymphoproliferative-associated disease and primary cardiac T-cell lymphoma in a STK4 deficient patient: A case report.Medicine (Baltimore). 2017 Dec;96(48):e8852. doi: 10.1097/MD.0000000000008852.
|
| 100 |
PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas.Blood. 2019 May 30;133(22):2401-2412. doi: 10.1182/blood.2018889931. Epub 2019 Apr 11.
|
| 101 |
UCH-L1 is induced in germinal center B cells and identifies patients with aggressive germinal center diffuse large B-cell lymphoma.Blood. 2016 Mar 24;127(12):1564-74. doi: 10.1182/blood-2015-07-656678. Epub 2015 Dec 23.
|
| 102 |
t(X;14)(p11;q32) in MALT lymphoma involving GPR34 reveals a role for GPR34 in tumor cell growth.Blood. 2012 Nov 8;120(19):3949-57. doi: 10.1182/blood-2011-11-389908. Epub 2012 Sep 10.
|
| 103 |
Interplay between HGAL and Grb2 proteins regulates B-cell receptor signaling.Blood Adv. 2019 Aug 13;3(15):2286-2297. doi: 10.1182/bloodadvances.2018016162.
|
| 104 |
Small-Molecule Inhibition of PD-1 Transcription Is an Effective Alternative to Antibody Blockade in Cancer Therapy.Cancer Res. 2018 Feb 1;78(3):706-717. doi: 10.1158/0008-5472.CAN-17-0491. Epub 2017 Oct 20.
|
| 105 |
Expression of granzyme B sensitizes ALK+ ALCL tumour cells to apoptosis-inducing drugs.Mol Cancer. 2014 Aug 29;13:199. doi: 10.1186/1476-4598-13-199.
|
| 106 |
Activation of MET signaling by HDAC6 offers a rationale for a novel ricolinostat and crizotinib combinatorial therapeutic strategy in diffuse large B-cell lymphoma.J Pathol. 2018 Oct;246(2):141-153. doi: 10.1002/path.5108. Epub 2018 Aug 20.
|
| 107 |
The transcriptional repressor HDAC7 promotes apoptosis and c-Myc downregulation in particular types of leukemia and lymphoma.Cell Death Dis. 2015 Feb 12;6(2):e1635. doi: 10.1038/cddis.2014.594.
|
| 108 |
Correction: Predictive biomarkers for disease sensitivity in lymphoma - the holy grail for HDAC inhibitors?.Oncotarget. 2019 Feb 26;10(17):1661. doi: 10.18632/oncotarget.26767. eCollection 2019 Feb 26.
|
| 109 |
Coexpression of B-lymphoma Moloney murine leukemia virus insertion region-1 and sex-determining region of Y chromosome-related high mobility group box-2 in cervical carcinogenesis.Hum Pathol. 2013 Feb;44(2):208-17. doi: 10.1016/j.humpath.2012.02.020. Epub 2012 Aug 3.
|
| 110 |
The heparanase inhibitor PG545 is a potent anti-lymphoma drug: Mode of action.Matrix Biol. 2019 Apr;77:58-72. doi: 10.1016/j.matbio.2018.08.005. Epub 2018 Aug 7.
|
| 111 |
Ganetespib synergizes with cyclophosphamide to improve survival of mice with autochthonous tumors in a mutant p53-dependent manner.Cell Death Dis. 2017 Mar 16;8(3):e2683. doi: 10.1038/cddis.2017.108.
|
| 112 |
HSPB8 is methylated in hematopoietic malignancies and overexpression of HSPB8 exhibits antileukemia effect.Exp Hematol. 2012 Jan;40(1):14-21. doi: 10.1016/j.exphem.2011.09.004. Epub 2011 Sep 10.
|
| 113 |
Growth-inhibition of cell lines derived from B cell lymphomas through antagonism of serotonin receptor signaling.Sci Rep. 2019 Mar 12;9(1):4276. doi: 10.1038/s41598-019-40825-x.
|
| 114 |
Chromosome analyses in chronic lymphocytic leukemia and related B-cell neoplasms.Cancer Genet Cytogenet. 1991 Aug;55(1):49-56. doi: 10.1016/0165-4608(91)90234-l.
|
| 115 |
Absence of Grail promotes CD8(+) T cell anti-tumour activity.Nat Commun. 2017 Aug 10;8(1):239. doi: 10.1038/s41467-017-00252-w.
|
| 116 |
The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia.Blood. 2012 Mar 15;119(11):2590-4. doi: 10.1182/blood-2011-11-390989. Epub 2012 Jan 25.
|
| 117 |
Th17 cytokine differentiation and loss of plasticity after SOCS1 inactivation in a cutaneous T-cell lymphoma.Oncotarget. 2016 Jun 7;7(23):34201-16. doi: 10.18632/oncotarget.9077.
|
| 118 |
JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma. Leukemia. 2014 Feb;28(2):338-48. doi: 10.1038/leu.2013.157. Epub 2013 May 21.
|
| 119 |
Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth.Nature. 2018 Aug;560(7717):253-257. doi: 10.1038/s41586-018-0387-5. Epub 2018 Aug 1.
|
| 120 |
Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.Blood. 2010 May 13;115(19):3960-5. doi: 10.1182/blood-2009-10-250134. Epub 2010 Mar 5.
|
| 121 |
Ongoing monoclonal B-cell proliferation is not common in gastric B-cell lymphoma after combined radiochemotherapy.J Clin Oncol. 2004 Aug 1;22(15):3039-45. doi: 10.1200/JCO.2004.08.177.
|
| 122 |
High intratumoural galectin-1 expression predicts adverse outcome in ALK(-) ALCL and CD30(+) PTCL-NOS.Hematol Oncol. 2020 Feb;38(1):59-66. doi: 10.1002/hon.2702. Epub 2020 Jan 1.
|
| 123 |
Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy era.AIDS. 2017 Nov 28;31(18):2493-2501. doi: 10.1097/QAD.0000000000001652.
|
| 124 |
Post-translational Modifications of the CARMA1-BCL10-MALT1 Complex in Lymphocytes and Activated B-Cell Like Subtype of Diffuse Large B-Cell Lymphoma.Front Oncol. 2018 Nov 9;8:498. doi: 10.3389/fonc.2018.00498. eCollection 2018.
|
| 125 |
Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy.Lancet. 2001 Jan 6;357(9249):39-40. doi: 10.1016/S0140-6736(00)03571-6.
|
| 126 |
Novel phosphorylated TAK1 species with functional impact on NF-B and -catenin signaling in human Cutaneous T-cell lymphoma.Leukemia. 2018 Oct;32(10):2211-2223. doi: 10.1038/s41375-018-0066-4. Epub 2018 Feb 22.
|
| 127 |
The Effects of Lentivirus-mediated shRNA Interference Targeting Mcl-1 on Growth of NK/T-cell Lymphoma.Neoplasma. 2017;64(4):511-517. doi: 10.4149/neo_2017_404.
|
| 128 |
Mutational landscape of T-cell lymphoma in mice lacking the DNA mismatch repair gene Mlh1: no synergism with ionizing radiation.Carcinogenesis. 2019 Apr 29;40(2):216-224. doi: 10.1093/carcin/bgz013.
|
| 129 |
Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients.Blood. 2017 Apr 13;129(15):2143-2147. doi: 10.1182/blood-2016-10-747477. Epub 2017 Jan 31.
|
| 130 |
Flow cytometry aneuploidy and cell cycle indexing as a possible tool for differentiating between CD10(+) diffuse large B-cell lymphoma and follicular lymphoma.Cytometry B Clin Cytom. 2020 Sep;98(5):449-453. doi: 10.1002/cyto.b.21861. Epub 2019 Dec 9.
|
| 131 |
Two cases of aquaporin-4 positive neuromyelitis optica associated with T-cell lymphoma.J Neuroimmunol. 2020 Jan 15;338:577092. doi: 10.1016/j.jneuroim.2019.577092. Epub 2019 Oct 30.
|
| 132 |
Non-Hodgkin lymphoma related to hereditary nonpolyposis colorectal cancer in a patient with a novel heterozygous complex deletion in the MSH2 gene.Genes Chromosomes Cancer. 2008 Apr;47(4):326-32. doi: 10.1002/gcc.20536.
|
| 133 |
The anti-invasive role of novel synthesized pyridazine hydrazide appended phenoxy acetic acid against neoplastic development targeting matrix metallo proteases.Biomed Pharmacother. 2017 Nov;95:375-386. doi: 10.1016/j.biopha.2017.08.105. Epub 2017 Sep 12.
|
| 134 |
MYD88 L265P MUTATION DETECTION IN THE AQUEOUS HUMOR OF PATIENTS WITH VITREORETINAL LYMPHOMA.Retina. 2019 Apr;39(4):679-684. doi: 10.1097/IAE.0000000000002319.
|
| 135 |
Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma show alterations of genes encoding the NADPH oxidase complex and impaired reactive oxygen species synthesis capacity.PLoS One. 2013 Dec 23;8(12):e84928. doi: 10.1371/journal.pone.0084928. eCollection 2013.
|
| 136 |
Discovery of a novel natural killer cell line with distinct immunostimulatory and proliferative potential as an alternative platform for cancer immunotherapy.J Immunother Cancer. 2019 May 24;7(1):138. doi: 10.1186/s40425-019-0612-2.
|
| 137 |
Enhanced antitumor effect of cisplatin in human oral squamous cell carcinoma cells by tumor suppressor GRIM?9.Mol Med Rep. 2015 Dec;12(6):8185-92. doi: 10.3892/mmr.2015.4423. Epub 2015 Oct 9.
|
| 138 |
Myc suppression of Nfkb2 accelerates lymphomagenesis.BMC Cancer. 2010 Jul 2;10:348. doi: 10.1186/1471-2407-10-348.
|
| 139 |
NDPKA is not just a metastasis suppressor - be aware of its metastasis-promoting role in neuroblastoma.Lab Invest. 2018 Feb;98(2):219-227. doi: 10.1038/labinvest.2017.105. Epub 2017 Oct 9.
|
| 140 |
SHP-1 promoter 2 methylation in normal epithelial tissues and demethylation in psoriasis.J Mol Med (Berl). 2006 Feb;84(2):175-82. doi: 10.1007/s00109-005-0020-6. Epub 2005 Dec 31.
|
| 141 |
Differential PAX5 levels promote malignant B-cell infiltration, progression and drug resistance, and predict a poor prognosis in MCL patients independent of CCND1.Leukemia. 2016 Mar;30(3):580-93. doi: 10.1038/leu.2015.140. Epub 2015 May 15.
|
| 142 |
PBK/TOPK is a novel mitotic kinase which is upregulated in Burkitt's lymphoma and other highly proliferative malignant cells.Blood Cells Mol Dis. 2001 Sep-Oct;27(5):825-9. doi: 10.1006/bcmd.2001.0452.
|
| 143 |
Pim2 cooperates with PML-RARalpha to induce acute myeloid leukemia in a bone marrow transplantation model.Blood. 2010 Jun 3;115(22):4507-16. doi: 10.1182/blood-2009-03-210070. Epub 2010 Mar 9.
|
| 144 |
The telomerase inhibitor PinX1 is a major haploinsufficient tumor suppressor essential for chromosome stability in mice.J Clin Invest. 2011 Apr;121(4):1266-82. doi: 10.1172/JCI43452. Epub 2011 Mar 23.
|
| 145 |
The deregulated promoter methylation of the Polo-like kinases as a potential biomarker in hematological malignancies.Leuk Lymphoma. 2015 Jul;56(7):2123-33. doi: 10.3109/10428194.2014.971407. Epub 2015 Jan 24.
|
| 146 |
Mantle cell lymphoma salvage regimen: synergy between a reprogrammed oncolytic virus and two chemotherapeutics.Gene Ther. 2010 Dec;17(12):1506-16. doi: 10.1038/gt.2010.103. Epub 2010 Aug 5.
|
| 147 |
The heat shock protein-90 co-chaperone, Cyclophilin 40, promotes ALK-positive, anaplastic large cell lymphoma viability and its expression is regulated by the NPM-ALK oncoprotein.BMC Cancer. 2012 Jun 8;12:229. doi: 10.1186/1471-2407-12-229.
|
| 148 |
Metronomic therapy for refractory/relapsed lymphoma: the PEP-C low-dose oral combination chemotherapy regimen.Hematology. 2012 Apr;17 Suppl 1:S90-2. doi: 10.1179/102453312X13336169155970.
|
| 149 |
Protein arginine methyltransferase 5 (PRMT5) promotes survival of lymphoma cells via activation of WNT/-catenin and AKT/GSK3 proliferative signaling.J Biol Chem. 2019 May 10;294(19):7692-7710. doi: 10.1074/jbc.RA119.007640. Epub 2019 Mar 18.
|
| 150 |
Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins.J Clin Oncol. 2014 Mar 10;32(8):798-808. doi: 10.1200/JCO.2013.51.5304. Epub 2013 Dec 16.
|
| 151 |
Polymorphisms in integrin genes and lymphoma risk.Leuk Res. 2011 Jul;35(7):968-70. doi: 10.1016/j.leukres.2010.12.012. Epub 2011 Jan 15.
|
| 152 |
Development of new PTK7-targeting aptamer-fluorescent and -radiolabelled probes for evaluation as molecular imaging agents: Lymphoma and melanoma in vivo proof of concept.Bioorg Med Chem. 2017 Feb 1;25(3):1163-1171. doi: 10.1016/j.bmc.2016.12.026. Epub 2016 Dec 24.
|
| 153 |
TC-PTP and PTP1B: Regulating JAK-STAT signaling, controlling lymphoid malignancies.Cytokine. 2016 Jun;82:52-7. doi: 10.1016/j.cyto.2015.12.025. Epub 2016 Jan 23.
|
| 154 |
5-Azacitidine induces demethylation of PTPL1 and inhibits growth in non-Hodgkin lymphoma.Int J Mol Med. 2015 Sep;36(3):698-704. doi: 10.3892/ijmm.2015.2269. Epub 2015 Jul 1.
|
| 155 |
Benzoquinone, a leukemogenic metabolite of benzene, catalytically inhibits the protein tyrosine phosphatase PTPN2 and alters STAT1 signaling.J Biol Chem. 2019 Aug 16;294(33):12483-12494. doi: 10.1074/jbc.RA119.008666. Epub 2019 Jun 27.
|
| 156 |
EBV and KSHV Infection Dysregulates Autophagy to Optimize Viral Replication, Prevent Immune Recognition and Promote Tumorigenesis.Viruses. 2018 Oct 31;10(11):599. doi: 10.3390/v10110599.
|
| 157 |
PKK deficiency in B cells prevents lupus development in Sle lupus mice.Immunol Lett. 2017 May;185:1-11. doi: 10.1016/j.imlet.2017.03.002. Epub 2017 Mar 6.
|
| 158 |
Cell cycle and apoptosis regulatory protein (CARP)-1 is a novel, adriamycin-inducible, diffuse large B-cell lymphoma (DLBL) growth suppressor.Cancer Chemother Pharmacol. 2011 Jun;67(6):1401-13. doi: 10.1007/s00280-010-1442-6. Epub 2010 Aug 31.
|
| 159 |
Retinoic Acid Receptor-Related Orphan Receptors: Critical Roles in Tumorigenesis.Front Immunol. 2018 May 31;9:1187. doi: 10.3389/fimmu.2018.01187. eCollection 2018.
|
| 160 |
SUMOylation Confers Posttranslational Stability on NPM-ALK Oncogenic Protein.Neoplasia. 2015 Sep;17(9):742-754. doi: 10.1016/j.neo.2015.09.005.
|
| 161 |
Runx1 Orchestrates Sphingolipid Metabolism and Glucocorticoid Resistance in Lymphomagenesis.J Cell Biochem. 2017 Jun;118(6):1432-1441. doi: 10.1002/jcb.25802. Epub 2017 Jan 10.
|
| 162 |
Collaboration of MYC and RUNX2 in lymphoma simulates T-cell receptor signaling and attenuates p53 pathway activity.J Cell Biochem. 2019 Oct;120(10):18332-18345. doi: 10.1002/jcb.29143. Epub 2019 Jun 30.
|
| 163 |
Targeting sphingosine kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphoma.Mol Cancer Ther. 2014 Jan;13(1):154-64. doi: 10.1158/1535-7163.MCT-13-0466. Epub 2013 Oct 18.
|
| 164 |
STK38 is a critical upstream regulator of MYC's oncogenic activity in human B-cell lymphoma.Oncogene. 2013 Nov 7;32(45):5283-91. doi: 10.1038/onc.2012.543. Epub 2012 Nov 26.
|
| 165 |
EBV Negative Lymphoma and Autoimmune Lymphoproliferative Syndrome Like Phenotype Extend the Clinical Spectrum of Primary Immunodeficiency Caused by STK4 Deficiency.Front Immunol. 2018 Oct 16;9:2400. doi: 10.3389/fimmu.2018.02400. eCollection 2018.
|
| 166 |
SYK regulates mTOR signaling in AML.Leukemia. 2013 Nov;27(11):2118-28. doi: 10.1038/leu.2013.89. Epub 2013 Mar 28.
|
| 167 |
Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing. J Invest Dermatol. 2017 Sep;137(9):1984-1994. doi: 10.1016/j.jid.2017.04.010. Epub 2017 May 4.
|
| 168 |
The NF-B subunit c-Rel regulates Bach2 tumour suppressor expression in B-cell lymphoma.Oncogene. 2016 Jun 30;35(26):3476-84. doi: 10.1038/onc.2015.399. Epub 2015 Nov 2.
|
| 169 |
Gene dosage reductions of Trf1 and/or Tin2 induce telomere DNA damage and lymphoma formation in aging mice.Leukemia. 2017 Dec;31(12):2853. doi: 10.1038/leu.2017.224. Epub 2017 Nov 10.
|
| 170 |
Up-regulation of T-lymphoma and metastasis gene 1 in gastric cancer and its involvement in cell invasion and migration.Chin Med J (Engl). 2013 Feb;126(4):640-5.
|
| 171 |
TIRAP p.R81C is a novel lymphoma risk variant which enhances cell proliferation via NF-B mediated signaling in B-cells.Haematologica. 2019 Apr;104(4):766-777. doi: 10.3324/haematol.2018.201590. Epub 2018 Oct 31.
|
| 172 |
A sensitive and kinetically defined radiochemical assay for canine and human serum thymidine kinase 1 (TK1) to monitor canine malignant lymphoma.Vet J. 2012 Oct;194(1):40-7. doi: 10.1016/j.tvjl.2012.03.006. Epub 2012 Apr 18.
|
| 173 |
CD8-independent tumor cell recognition is a property of the T cell receptor and not the T cell.J Immunol. 2003 Mar 1;170(5):2582-9. doi: 10.4049/jimmunol.170.5.2582.
|
| 174 |
Breast Cancer (18)F-ISO-1 Uptake as a Marker of Proliferation Status.J Nucl Med. 2020 May;61(5):665-670. doi: 10.2967/jnumed.119.232363. Epub 2019 Dec 13.
|
| 175 |
Development of a high-resolution melting method for the screening of TNFAIP3 gene mutations.Oncol Rep. 2016 May;35(5):2936-42. doi: 10.3892/or.2016.4662. Epub 2016 Mar 8.
|
| 176 |
Genetic variants in interleukin-2 and risk of lymphoma among children in Korea.Asian Pac J Cancer Prev. 2012;13(2):621-3. doi: 10.7314/apjcp.2012.13.2.621.
|
| 177 |
CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies.Sci Transl Med. 2019 Sep 25;11(511):eaaw9414. doi: 10.1126/scitranslmed.aaw9414.
|
| 178 |
Enhancing immunotherapy of STING agonist for lymphoma in preclinical models.Blood Adv. 2018 Sep 11;2(17):2230-2241. doi: 10.1182/bloodadvances.2018020040.
|
| 179 |
Augmentation of CD134 (OX40)-dependent NK anti-tumour activity is dependent on antibody cross-linking.Sci Rep. 2018 Feb 2;8(1):2278. doi: 10.1038/s41598-018-20656-y.
|
| 180 |
CD137 deficiency causes immune dysregulation with predisposition to lymphomagenesis.Blood. 2019 Oct 31;134(18):1510-1516. doi: 10.1182/blood.2019000644.
|
| 181 |
Genetic contributors and soluble mediators in prediction of autoimmune comorbidity.J Autoimmun. 2019 Nov;104:102317. doi: 10.1016/j.jaut.2019.102317. Epub 2019 Aug 20.
|
| 182 |
Adenovirus-mediated LIGHT gene modification in murine B-cell lymphoma elicits a potent antitumor effect.Cell Mol Immunol. 2010 Jul;7(4):296-305. doi: 10.1038/cmi.2010.15. Epub 2010 Apr 26.
|
| 183 |
Combined cellular and soluble mediator analysis for improved diagnosis of vitreoretinal lymphoma.Acta Ophthalmol. 2019 Sep;97(6):626-632. doi: 10.1111/aos.14036. Epub 2019 Jan 27.
|
| 184 |
Kinome profiling of non-Hodgkin lymphoma identifies Tyro3 as a therapeutic target in primary effusion lymphoma.Proc Natl Acad Sci U S A. 2019 Aug 13;116(33):16541-16550. doi: 10.1073/pnas.1903991116. Epub 2019 Jul 25.
|
| 185 |
Wiskott-Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma.Nat Med. 2019 Jan;25(1):130-140. doi: 10.1038/s41591-018-0262-9. Epub 2018 Dec 3.
|
| 186 |
Rapid xenograft tumor progression in beta-arrestin1 transgenic mice due to enhanced tumor angiogenesis.FASEB J. 2008 Feb;22(2):355-64. doi: 10.1096/fj.07-9046com. Epub 2007 Sep 21.
|
| 187 |
Promoter methylation of the bone morphogenetic protein-6 gene in association with adult T-cell leukemia.Int J Cancer. 2008 Oct 15;123(8):1824-31. doi: 10.1002/ijc.23749.
|
| 188 |
Pharmacological inhibition of carbonic anhydrase XII interferes with cell proliferation and induces cell apoptosis in T-cell lymphomas.Cancer Lett. 2013 Jun 1;333(1):76-88. doi: 10.1016/j.canlet.2013.01.020. Epub 2013 Jan 21.
|
| 189 |
Jun activation domain-binding protein 1 negatively regulate p27 kip1 in non-Hodgkin's lymphomas.Cancer Biol Ther. 2008 Mar;7(3):460-7. doi: 10.4161/cbt.7.3.5456. Epub 2007 Dec 21.
|
| 190 |
Clinical significance of co-expression of CD21 and LFA-1 in B-cell lymphoma.Int J Hematol. 2009 May;89(4):497-507. doi: 10.1007/s12185-009-0303-8. Epub 2009 Apr 11.
|
| 191 |
Regulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver.World J Gastroenterol. 2013 May 21;19(19):2883-93. doi: 10.3748/wjg.v19.i19.2883.
|
| 192 |
Allorestricted T cells with specificity for the FMNL1-derived peptide PP2 have potent antitumor activity against hematologic and other malignancies.Blood. 2007 Oct 15;110(8):2931-9. doi: 10.1182/blood-2006-11-058750. Epub 2007 Jul 12.
|
| 193 |
Human T-leukemia and T-lymphoma express glutamate receptor AMPA GluR3, and the neurotransmitter glutamate elevates the cancer-related matrix-metalloproteinases inducer CD147/EMMPRIN, MMP-9 secretion and engraftment of T-leukemia in vivo.Leuk Lymphoma. 2009 Jun;50(6):985-97. doi: 10.1080/10428190902878448.
|
| 194 |
CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia.Haematologica. 2019 Apr;104(4):749-755. doi: 10.3324/haematol.2018.205252. Epub 2018 Oct 25.
|
| 195 |
A novel monoclonal antibody, KOR-SA3544 which reacts to Philadelphia chromosome-positive acute lymphoblastic leukemia cells with high sensitivity.Leukemia. 1995 Jul;9(7):1233-9.
|
| 196 |
PDCD2, a protein whose expression is repressed by BCL6, induces apoptosis in human cells by activation of the caspase cascade.Blood Cells Mol Dis. 2010 Aug 15;45(2):169-75. doi: 10.1016/j.bcmd.2010.04.007. Epub 2010 Jun 3.
|
| 197 |
A novel TRB@/NOTCH1 fusion gene in T-cell lymphoblastic lymphoma with t(7;9)(q34;q34).Eur J Haematol. 2013 Jan;90(1):68-75. doi: 10.1111/ejh.12019. Epub 2012 Nov 29.
|
| 198 |
Cell cycle arrest induced by engagement of B7-H4 on Epstein-Barr virus-positive B-cell lymphoma cell lines.Immunology. 2009 Nov;128(3):360-8. doi: 10.1111/j.1365-2567.2009.03111.x.
|
| 199 |
Expression of ABCB5 gene in hematological malignances and its significance.Leuk Lymphoma. 2012 Jun;53(6):1211-5. doi: 10.3109/10428194.2011.637214. Epub 2011 Dec 7.
|
| 200 |
UGT1A1 *6 polymorphism predicts outcome in elderly patients with relapsed or refractory diffuse large B-cell lymphoma treated with carboplatin, dexamethasone, etoposide and irinotecan.Ann Hematol. 2015 Jan;94(1):65-9. doi: 10.1007/s00277-014-2170-5. Epub 2014 Jul 25.
|
| 201 |
Prognostic Value of Accumulative Expression of COX-2 and p53 in Small and Diffuse Large B Cell Lymphoma.Pathol Oncol Res. 2020 Apr;26(2):1183-1190. doi: 10.1007/s12253-019-00674-5. Epub 2019 Jun 11.
|
| 202 |
Uridine kinase: altered subunit size or enzyme expression as a function of cell type, growth stimulation, or mutagenesis.J Cell Biochem. 1987 Nov;35(3):217-29. doi: 10.1002/jcb.240350305.
|
| 203 |
Bendamustine with rituximab, etoposide and carboplatin (T(R)EC) in relapsed or refractory aggressive lymphoma: a prospective multicentre phase 1/2 clinical trial.Br J Haematol. 2018 Nov;183(4):601-607. doi: 10.1111/bjh.15585. Epub 2018 Sep 14.
|
| 204 |
N-acetyltransferase polymorphisms are associated with risk of lymphoma subtypes.Hematol Oncol. 2016 Jun;34(2):79-83. doi: 10.1002/hon.2193. Epub 2015 Feb 17.
|
| 205 |
Increased expression of the spindle checkpoint protein BubR1 is associated with high cell proliferation in primary gastrointestinal diffuse large B cell lymphoma.Cell Biochem Biophys. 2013 Jul;66(3):747-52. doi: 10.1007/s12013-013-9519-6.
|
| 206 |
The early variation of left ventricular twisting function in patients with lymphoma received anthracycline therapy assessed by three-dimensional speckle tracking echocardiography.Cardiol J. 2017;24(5):484-494. doi: 10.5603/CJ.a2017.0035. Epub 2017 Mar 29.
|
| 207 |
Lack of topoisomerase copy number changes in patients with de novo and relapsed diffuse large B-cell lymphoma.Exp Hematol. 2015 Jul;43(7):534-6. doi: 10.1016/j.exphem.2015.04.006. Epub 2015 Apr 27.
|
| 208 |
A rare case of asynchronous bilateral B-cell lymphoma of the breast.Jpn J Clin Oncol. 1989 Dec;19(4):391-6.
|
| 209 |
The lymphocyte metalloprotease MDC-L (ADAM 28) is a ligand for the integrin alpha4beta1.J Biol Chem. 2002 Feb 1;277(5):3784-92. doi: 10.1074/jbc.M109538200. Epub 2001 Nov 27.
|
| 210 |
Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization.Blood. 1989 Aug 1;74(2):810-6.
|
| 211 |
Single and combined BTK and PI3K inhibition with acalabrutinib and ACP-319 in pre-clinical models of aggressive lymphomas.Br J Haematol. 2019 Dec;187(5):595-601. doi: 10.1111/bjh.16118. Epub 2019 Jul 29.
|
| 212 |
Five-year study assessing the clinical utility of anti-Mllerian hormone measurements in reproductive-age women with cancer.Reprod Biomed Online. 2019 Oct;39(4):712-720. doi: 10.1016/j.rbmo.2019.06.001. Epub 2019 Jun 11.
|
| 213 |
Plasma membrane sequestration of apoptotic protease-activating factor-1 in human B-lymphoma cells: a novel mechanism of chemoresistance.Blood. 2005 May 15;105(10):4070-7. doi: 10.1182/blood-2004-10-4075. Epub 2005 Feb 3.
|
| 214 |
Enhanced tumor formation in mice heterozygous for Blm mutation.Science. 2002 Sep 20;297(5589):2051-3. doi: 10.1126/science.1074340.
|
| 215 |
Concise Review: Cheating Death for a Better Transplant.Stem Cells. 2018 Nov;36(11):1646-1654. doi: 10.1002/stem.2901. Epub 2018 Oct 1.
|
| 216 |
CART cell therapy for prostate cancer: status and promise.Onco Targets Ther. 2019 Jan 3;12:391-395. doi: 10.2147/OTT.S185556. eCollection 2019.
|
| 217 |
Overexpression of CCDC34 in colorectal cancer and its involvement in tumor growth, apoptosis and invasion.Mol Med Rep. 2018 Jan;17(1):465-473. doi: 10.3892/mmr.2017.7860. Epub 2017 Oct 24.
|
| 218 |
Id2 Collaborates with Id3 To Suppress Invariant NKT and Innate-like Tumors.J Immunol. 2017 Apr 15;198(8):3136-3148. doi: 10.4049/jimmunol.1601935. Epub 2017 Mar 3.
|
| 219 |
Anaplastic variant of diffuse large B-cell lymphoma with hallmark cell appearance: Two cases highlighting a broad diversity in the diagnostics.Pathol Int. 2018 Apr;68(4):251-255. doi: 10.1111/pin.12653. Epub 2018 Feb 25.
|
| 220 |
p53 expression in large B-cell lymphomas with MYC extra copies and CD99 expression in large B-cell lymphomas in relation to MYC status.Hum Pathol. 2019 Apr;86:21-31. doi: 10.1016/j.humpath.2018.11.015. Epub 2018 Nov 26.
|
| 221 |
Structural abnormalities of the X chromosome in non-Hodgkin's lymphoma.Leukemia. 1993 Jun;7(6):848-52.
|
| 222 |
ALK-positive diffuse large B-cell lymphoma of the stomach associated with a clathrin-ALK rearrangement.Hum Pathol. 2004 Oct;35(10):1285-8. doi: 10.1016/j.humpath.2004.06.001.
|
| 223 |
Reduced oncogenicity of p190 Bcr/Abl F-actin-binding domain mutants.Blood. 2000 Sep 15;96(6):2226-32.
|
| 224 |
Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry.Blood. 1994 Dec 1;84(11):3648-52.
|
| 225 |
Proposed rituximab biosimilar BCD-020 versus reference rituximab for treatment of patients with indolent non-Hodgkin lymphomas: An international multicenter randomized trial.Hematol Oncol. 2020 Feb;38(1):67-73. doi: 10.1002/hon.2693. Epub 2020 Jan 13.
|
| 226 |
VASA is a specific marker for both normal and malignant human germ cells.Lab Invest. 2002 Feb;82(2):159-66. doi: 10.1038/labinvest.3780408.
|
| 227 |
Interphase detection of BCL6/IgH fusion gene in non-Hodgkin lymphoma by fluorescence in situ hybridization.Cancer Genet Cytogenet. 1997 Dec;99(2):102-7. doi: 10.1016/s0165-4608(97)00203-3.
|
| 228 |
Expression of DHX32 in lymphoid tissues.Exp Mol Pathol. 2005 Dec;79(3):219-23. doi: 10.1016/j.yexmp.2005.07.002. Epub 2005 Sep 21.
|
| 229 |
BET Inhibition-Induced GSK3 Feedback Enhances Lymphoma Vulnerability to PI3K Inhibitors.Cell Rep. 2018 Aug 21;24(8):2155-2166. doi: 10.1016/j.celrep.2018.07.055.
|
| 230 |
Isolation and characterization of bovine and mouse terminal deoxynucleotidyltransferase cDNAs expressible in mammalian cells.Nucleic Acids Res. 1986 Jul 25;14(14):5777-92. doi: 10.1093/nar/14.14.5777.
|
| 231 |
Methodology, Criteria, and Characterization of Patient-Matched Thyroid Cell Lines and Patient-Derived Tumor Xenografts.J Clin Endocrinol Metab. 2018 Sep 1;103(9):3169-3182. doi: 10.1210/jc.2017-01845.
|
| 232 |
Round cell tumours of bone.Pathol Res Pract. 1993 Dec;189(10):111-36.
|
| 233 |
NSE from diffuse large B-cell lymphoma cells regulates macrophage polarization.Cancer Manag Res. 2019 May 17;11:4577-4595. doi: 10.2147/CMAR.S203010. eCollection 2019.
|
| 234 |
Berberine reinforces Sertoli cells niche and accelerates spermatogonial stem cells renewal in experimentally-induced varicocele condition in rats.Phytomedicine. 2018 Feb 1;40:68-78. doi: 10.1016/j.phymed.2017.12.036. Epub 2018 Jan 2.
|
| 235 |
The novel ETS factor TEL2 cooperates with Myc in B lymphomagenesis.Mol Cell Biol. 2005 Mar;25(6):2395-405. doi: 10.1128/MCB.25.6.2395-2405.2005.
|
| 236 |
Immunoglobulin superfamily receptor translocation associated 2 protein on lymphoma cell lines and hairy cell leukemia cells detected by novel monoclonal antibodies.Clin Cancer Res. 2005 Jan 1;11(1):87-96.
|
| 237 |
Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.Clin Cancer Res. 2005 Dec 1;11(23):8250-7. doi: 10.1158/1078-0432.CCR-05-1426.
|
| 238 |
The human placental growth hormone variant is mitogenic for rat lymphoma Nb2 cells.Endocrinology. 1990 Feb;126(2):971-6. doi: 10.1210/endo-126-2-971.
|
| 239 |
Agranular CD4+CD56+ blastic natural killer leukemia/lymphoma.Ann Hematol. 2001 Apr;80(4):228-31. doi: 10.1007/s002770000257.
|
| 240 |
Haptoglobin-related protein as a serum marker in malignant lymphoma.Pathol Oncol Res. 1998;4(4):271-6. doi: 10.1007/BF02905217.
|
| 241 |
The adaptor protein HSH2 attenuates apoptosis in response to ligation of the B cell antigen receptor complex on the B lymphoma cell line, WEHI-231.J Biol Chem. 2005 Feb 4;280(5):3507-15. doi: 10.1074/jbc.M407690200. Epub 2004 Nov 29.
|
| 242 |
Expression of HYAL2 mRNA, hyaluronan and hyaluronidase in B-cell non-Hodgkin lymphoma: relationship with tumor aggressiveness.Int J Cancer. 2005 Jan 10;113(2):207-12. doi: 10.1002/ijc.20562.
|
| 243 |
A variant Burkitt-type translocation (2p-;8q+) in a patient with diffuse large cell lymphoma.Cancer Genet Cytogenet. 1987 Feb;24(2):225-9. doi: 10.1016/0165-4608(87)90103-8.
|
| 244 |
T(11;18)-bearing pulmonary mucosa-associated lymphoid tissue lymphoma responding to cladribine.Int J Hematol. 2004 Jul;80(1):70-4. doi: 10.1532/ijh97.03170.
|
| 245 |
Primary gastric T-cell lymphoma with and without human T-lymphotropic virus type 1.Cancer. 1997 Jul 15;80(2):292-303. doi: 10.1002/(sici)1097-0142(19970715)80:2<292::aid-cncr18>3.0.co;2-p.
|
| 246 |
Epstein-Barr virus-negative extranodal "true" natural killer-cell lymphoma harbouring a KDM6A mutation.Hematol Oncol. 2018 Feb;36(1):328-335. doi: 10.1002/hon.2459. Epub 2017 Jul 10.
|
| 247 |
Primary malignant lymphoma of the brain: frequent abnormalities and inactivation of p14 tumor suppressor gene.Cancer Sci. 2005 Jan;96(1):38-41. doi: 10.1111/j.1349-7006.2005.00003.x.
|
| 248 |
Expression of the MDR1 and MRP genes in patients with lymphoma with primary bone marrow involvement.Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(6-7):843-7. doi: 10.1081/NCN-200026029.
|
| 249 |
Systemic therapy in non-conventional cancers of the larynx.Oral Oncol. 2018 Jul;82:61-68. doi: 10.1016/j.oraloncology.2018.05.005. Epub 2018 May 26.
|
| 250 |
Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.Eur J Immunol. 1995 May;25(5):1374-84. doi: 10.1002/eji.1830250536.
|
| 251 |
A novel diffuse large B-cell lymphoma-associated cancer testis antigen encoding a PAS domain protein.Br J Cancer. 2004 Jul 5;91(1):141-9. doi: 10.1038/sj.bjc.6601875.
|
| 252 |
Deletion of the Miz-1 POZ Domain Increases Efficacy of Cytarabine Treatment in T- and B-ALL/Lymphoma Mouse Models.Cancer Res. 2019 Aug 15;79(16):4184-4195. doi: 10.1158/0008-5472.CAN-18-3038. Epub 2019 Jul 4.
|
| 253 |
TAPP1 and TAPP2 are targets of phosphatidylinositol 3-kinase signaling in B cells: sustained plasma membrane recruitment triggered by the B-cell antigen receptor.Mol Cell Biol. 2002 Aug;22(15):5479-91. doi: 10.1128/MCB.22.15.5479-5491.2002.
|
| 254 |
Germline variation in the 3'-untranslated region of the POU2AF1 gene is associated with susceptibility to lymphoma.Mol Carcinog. 2017 Aug;56(8):1945-1952. doi: 10.1002/mc.22652. Epub 2017 Apr 19.
|
| 255 |
Alterations of the PPP1R3 gene in hematological malignancies.Int J Oncol. 2000 Oct;17(4):717-21. doi: 10.3892/ijo.17.4.717.
|
| 256 |
New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.Anticancer Res. 2004 Mar-Apr;24(2B):865-71.
|
| 257 |
Mutations of a novel human RAD54 homologue, RAD54B, in primary cancer.Oncogene. 1999 Jun 3;18(22):3422-6. doi: 10.1038/sj.onc.1202691.
|
| 258 |
RAG1/2 induces genomic insertions by mobilizing DNA into RAG1/2-independent breaks.J Exp Med. 2017 Mar 6;214(3):815-831. doi: 10.1084/jem.20161638. Epub 2017 Feb 8.
|
| 259 |
Genetic alterations disrupting the nuclear localization of the retinoblastoma-related gene RB2/p130 in human tumor cell lines and primary tumors.Cancer Res. 2000 Jan 15;60(2):383-9.
|
| 260 |
Hypermethylation-associated Inactivation of the Cellular Retinol-Binding-Protein 1 Gene in Human Cancer.Cancer Res. 2002 Oct 15;62(20):5902-5.
|
| 261 |
The regulator of calcineurin 1 (RCAN1) inhibits nuclear factor kappaB signaling pathway and suppresses human malignant glioma cells growth.Oncotarget. 2017 Feb 14;8(7):12003-12012. doi: 10.18632/oncotarget.14479.
|
| 262 |
Immunophenotypic Shifts in Primary Cutaneous T-Cell Lymphoma Suggest Antigenic Modulation: A Study of Sequential Biopsy Specimens.Am J Surg Pathol. 2017 Apr;41(4):431-445. doi: 10.1097/PAS.0000000000000786.
|
| 263 |
Homozygous deletions and point mutations of the Rit1/Bcl11b gene in gamma-ray induced mouse thymic lymphomas.Biochem Biophys Res Commun. 2003 Feb 7;301(2):598-603. doi: 10.1016/s0006-291x(02)03069-3.
|
| 264 |
Notch signal transduction is not regulated by SEL1L in leukaemia and lymphoma cells in culture.Anticancer Res. 2002 Nov-Dec;22(6C):4211-4.
|
| 265 |
The effects of a growth-inhibiting tripeptide, acetylGlu-Ser-GlyNH2 (Ac-ESG), on gene expression and cell cycle progression of two lymphoma cell lines.Anticancer Res. 2003 Jul-Aug;23(4):3159-65.
|
| 266 |
In vitro canine distemper virus infection of canine lymphoid cells: a prelude to oncolytic therapy for lymphoma.Clin Cancer Res. 2005 Feb 15;11(4):1579-87. doi: 10.1158/1078-0432.CCR-04-1944.
|
| 267 |
Ig VH gene expression among human follicular lymphomas.Blood. 1991 Sep 15;78(6):1561-8.
|
| 268 |
Purification, cDNA cloning, and expression of human sorcin in vincristine-resistant HOB1 lymphoma cell lines.Arch Biochem Biophys. 1996 Jan 15;325(2):217-26. doi: 10.1006/abbi.1996.0027.
|
| 269 |
Apoptosis stimulating protein of p53 (ASPP2) expression differs in diffuse large B-cell and follicular center lymphoma: correlation with clinical outcome.Leuk Lymphoma. 2002 Dec;43(12):2309-17. doi: 10.1080/1042819021000040017.
|
| 270 |
Effusion and solid lymphomas have distinctive gene and protein expression profiles in an animal model of primary effusion lymphoma.J Pathol. 2006 Aug;209(4):464-73. doi: 10.1002/path.2012.
|
| 271 |
Epm2a suppresses tumor growth in an immunocompromised host by inhibiting Wnt signaling.Cancer Cell. 2006 Sep;10(3):179-90. doi: 10.1016/j.ccr.2006.08.008.
|
| 272 |
Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis.Blood. 2005 Sep 1;106(5):1831-8. doi: 10.1182/blood-2004-10-3898. Epub 2005 May 24.
|
| 273 |
RGS1 and RGS13 mRNA silencing in a human B lymphoma line enhances responsiveness to chemoattractants and impairs desensitization.J Leukoc Biol. 2006 Jun;79(6):1357-68. doi: 10.1189/jlb.1105693. Epub 2006 Mar 24.
|
| 274 |
AHI-1: a novel signaling protein and potential therapeutic target in human leukemia and brain disorders.Oncotarget. 2011 Dec;2(12):918-34. doi: 10.18632/oncotarget.405.
|
| 275 |
Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells.Oncogene. 2007 May 31;26(26):3797-810. doi: 10.1038/sj.onc.1210152. Epub 2006 Dec 18.
|
| 276 |
Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma.Haematologica. 2017 Oct;102(10):1758-1766. doi: 10.3324/haematol.2016.160192. Epub 2017 Jul 27.
|
| 277 |
Protective effect of human serum amyloid P on CCl4-induced acute liver injury in mice.Int J Mol Med. 2017 Aug;40(2):454-464. doi: 10.3892/ijmm.2017.3028. Epub 2017 Jun 14.
|
| 278 |
Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors.Cancer Immunol Res. 2015 Jul;3(7):815-26. doi: 10.1158/2326-6066.CIR-15-0054. Epub 2015 May 4.
|
| 279 |
EBV latent membrane protein 2A orchestrates p27(kip1) degradation via Cks1 to accelerate MYC-driven lymphoma in mice.Blood. 2017 Dec 7;130(23):2516-2526. doi: 10.1182/blood-2017-07-796821. Epub 2017 Oct 26.
|
| 280 |
Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer.J Virol. 2008 Oct;82(19):9329-36. doi: 10.1128/JVI.00646-08. Epub 2008 Jul 16.
|
| 281 |
Identifying gene disruptions in novel balanced de novo constitutional translocations in childhood cancer patients by whole-genome sequencing.Genet Med. 2015 Oct;17(10):831-5. doi: 10.1038/gim.2014.189. Epub 2015 Jan 8.
|
| 282 |
DLC-1 as a modulator of proliferation, apoptosis and migration in Burkitt's lymphoma cells.Mol Biol Rep. 2011 Mar;38(3):1915-20. doi: 10.1007/s11033-010-0311-z. Epub 2010 Oct 1.
|
| 283 |
Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomas.J Transl Med. 2012 Oct 11;10:209. doi: 10.1186/1479-5876-10-209.
|
| 284 |
The Transcription Factor ASCIZ and Its Target DYNLL1 Are Essential for the Development and Expansion of MYC-Driven B Cell Lymphoma.Cell Rep. 2016 Feb 16;14(6):1488-1499. doi: 10.1016/j.celrep.2016.01.012. Epub 2016 Jan 28.
|
| 285 |
DNA repair gene polymorphisms in B cell non-Hodgkin's lymphoma.Tumour Biol. 2015 Mar;36(3):2155-61. doi: 10.1007/s13277-014-2825-9. Epub 2014 Nov 18.
|
| 286 |
Expression of syncytin in leukemia and lymphoma cells.Leuk Res. 2010 Sep;34(9):1195-202. doi: 10.1016/j.leukres.2010.03.016. Epub 2010 Apr 2.
|
| 287 |
Suppression of Myc oncogenic activity by nucleostemin haploinsufficiency.Oncogene. 2012 Jul 12;31(28):3311-21. doi: 10.1038/onc.2011.507. Epub 2011 Nov 14.
|
| 288 |
Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk.Genes Immun. 2006 Dec;7(8):615-24. doi: 10.1038/sj.gene.6364337. Epub 2006 Sep 14.
|
| 289 |
Mapping of transcription factor motifs in active chromatin identifies IRF5 as key regulator in classical Hodgkin lymphoma.Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):E4513-22. doi: 10.1073/pnas.1406985111. Epub 2014 Oct 6.
|
| 290 |
Killer cell immunoglobulin-like receptor 2DL4 is expressed in and suppresses the cell growth of Langerhans cell histiocytosis.Oncotarget. 2017 Jun 6;8(23):36964-36972. doi: 10.18632/oncotarget.16936.
|
| 291 |
Galectin-1-mediated cell adhesion, invasion and cell death in human anaplastic large cell lymphoma: regulatory roles of cell surface glycans.Int J Oncol. 2014 May;44(5):1433-42. doi: 10.3892/ijo.2014.2319. Epub 2014 Mar 4.
|
| 292 |
Increased galectin-7 gene expression in lymphoma cells is under the control of DNA methylation.Biochem Biophys Res Commun. 2009 Sep 25;387(3):425-9. doi: 10.1016/j.bbrc.2009.07.015. Epub 2009 Jul 9.
|
| 293 |
Latexin is down-regulated in hematopoietic malignancies and restoration of expression inhibits lymphoma growth.PLoS One. 2012;7(9):e44979. doi: 10.1371/journal.pone.0044979. Epub 2012 Sep 27.
|
| 294 |
The role of centrosomal Nlp in the control of mitotic progression and tumourigenesis.Br J Cancer. 2011 May 10;104(10):1523-8. doi: 10.1038/bjc.2011.130. Epub 2011 Apr 19.
|
| 295 |
Acquired STAT4 deficiency as a consequence of cancer chemotherapy.Blood. 2011 Dec 1;118(23):6097-106. doi: 10.1182/blood-2011-03-341867. Epub 2011 Oct 13.
|
| 296 |
Epigenetic inactivation of the Groucho homologue gene TLE1 in hematologic malignancies.Cancer Res. 2008 Jun 1;68(11):4116-22. doi: 10.1158/0008-5472.CAN-08-0085.
|
| 297 |
Transient responses to NOTCH and TLX1/HOX11 inhibition in T-cell acute lymphoblastic leukemia/lymphoma.PLoS One. 2011 Feb 4;6(2):e16761. doi: 10.1371/journal.pone.0016761.
|
| 298 |
Expression of a soluble decoy receptor 3 in patients with diffuse large B-cell lymphoma predicts clinical outcome.Int J Oncol. 2008 Sep;33(3):549-54.
|
| 299 |
Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas.Leukemia. 2011 Dec;25(12):1882-90. doi: 10.1038/leu.2011.168. Epub 2011 Jul 22.
|
| 300 |
Highly potent anti-CD20-RLI immunocytokine targeting established human B lymphoma in SCID mouse.MAbs. 2014 Jul-Aug;6(4):1026-37. doi: 10.4161/mabs.28699.
|
| 301 |
ACOX1 destabilizes p73 to suppress intrinsic apoptosis pathway and regulates sensitivity to doxorubicin in lymphoma cells.BMB Rep. 2019 Sep;52(9):566-571. doi: 10.5483/BMBRep.2019.52.9.094.
|
| 302 |
The CBFA2T3/ACSF3 locus is recurrently involved in IGH chromosomal translocation t(14;16)(q32;q24) in pediatric B-cell lymphoma with germinal center phenotype.Genes Chromosomes Cancer. 2012 Apr;51(4):338-43. doi: 10.1002/gcc.21919.
|
| 303 |
TFG, a target of chromosome translocations in lymphoma and soft tissue tumors, fuses to GPR128 in healthy individuals.Haematologica. 2010 Jan;95(1):20-6. doi: 10.3324/haematol.2009.011536. Epub 2009 Oct 1.
|
| 304 |
The clastogenicity of 4NQO is cell-type dependent and linked to cytotoxicity, length of exposure and p53 proficiency.Mutagenesis. 2016 Mar;31(2):171-80. doi: 10.1093/mutage/gev069. Epub 2015 Sep 11.
|
| 305 |
TP73, an under-appreciated player in non-Hodgkin lymphoma pathogenesis and management.Curr Mol Med. 2014 May;14(4):432-9. doi: 10.2174/1566524014666140414204458.
|
| 306 |
Crucial Role of Increased Arid3a at the Pre-B and Immature B Cell Stages for B1a Cell Generation.Front Immunol. 2019 Mar 15;10:457. doi: 10.3389/fimmu.2019.00457. eCollection 2019.
|
| 307 |
HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergies.Blood. 2014 Aug 21;124(8):1266-76. doi: 10.1182/blood-2014-03-563742. Epub 2014 Jun 26.
|
| 308 |
Sensitisation of c-MYC-induced B-lymphoma cells to apoptosis by ATF2.Oncogene. 2014 Feb 20;33(8):1027-36. doi: 10.1038/onc.2013.28. Epub 2013 Feb 18.
|
| 309 |
Case for diagnosis. Infective dermatitis associated with HTLV-1: differential diagnosis of atopic dermatitis.An Bras Dermatol. 2017 Jul-Aug;92(4):573-574. doi: 10.1590/abd1806-4841.20176684.
|
| 310 |
BAM conditioning before autologous transplantation for lymphoma: a study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).Ann Hematol. 2019 Aug;98(8):1973-1980. doi: 10.1007/s00277-019-03704-z. Epub 2019 May 20.
|
| 311 |
Body size and obesity during adulthood, and risk of lympho-haematopoietic cancers: an update of the WCRF-AICR systematic review of published prospective studies.Ann Oncol. 2019 Apr 1;30(4):528-541. doi: 10.1093/annonc/mdz045.
|
| 312 |
Intramolecular Interactions and Regulation of Cofactor Binding by the Four Repressive Elements in the Caspase Recruitment Domain-containing Protein 11 (CARD11) Inhibitory Domain.J Biol Chem. 2016 Apr 15;291(16):8338-48. doi: 10.1074/jbc.M116.717322. Epub 2016 Feb 16.
|
| 313 |
Targeting a mitochondrial potassium channel to fight cancer.Cell Calcium. 2015 Jul;58(1):131-8. doi: 10.1016/j.ceca.2014.09.006. Epub 2014 Oct 18.
|
| 314 |
Age-Related Gliosis Promotes Central Nervous System Lymphoma through CCL19-Mediated Tumor Cell Retention.Cancer Cell. 2019 Sep 16;36(3):250-267.e9. doi: 10.1016/j.ccell.2019.08.001.
|
| 315 |
CD2-Associated Protein Contributes to Hepatitis C, Virus Propagation and Steatosis by Disrupting Insulin Signaling.Hepatology. 2018 Nov;68(5):1710-1725. doi: 10.1002/hep.30073.
|
| 316 |
Signalling pathways identified in salivary glands from primary Sjgren's syndrome patients reveal enhanced adipose tissue development.Autoimmunity. 2018 May;51(3):135-146. doi: 10.1080/08916934.2018.1446525. Epub 2018 Mar 5.
|
| 317 |
Common variants on 14q32 and 13q12 are associated with DLBCL susceptibility.J Hum Genet. 2011 Jun;56(6):436-9. doi: 10.1038/jhg.2011.35. Epub 2011 Apr 7.
|
| 318 |
CDCA7 finely tunes cytoskeleton dynamics to promote lymphoma migration and invasion.Haematologica. 2020 Mar;105(3):730-740. doi: 10.3324/haematol.2018.215459. Epub 2019 Jun 20.
|
| 319 |
The Transitional Endoplasmic Reticulum ATPase p97 Regulates the Alternative Nuclear Factor NF-B Signaling via Partial Degradation of the NF-B Subunit p100.J Biol Chem. 2015 Aug 7;290(32):19558-68. doi: 10.1074/jbc.M114.630061. Epub 2015 Jun 25.
|
| 320 |
Congenital heart disease complexity and childhood cancer risk.Birth Defects Res. 2018 Oct 16;110(17):1314-1321. doi: 10.1002/bdr2.1390. Epub 2018 Oct 16.
|
| 321 |
Metabolic changes associated with metformin potentiates Bcl-2 inhibitor, Venetoclax, and CDK9 inhibitor, BAY1143572 and reduces viability of lymphoma cells.Oncotarget. 2018 Apr 20;9(30):21166-21181. doi: 10.18632/oncotarget.24989. eCollection 2018 Apr 20.
|
| 322 |
A novel protein CMTM1-v5 specifically induced human lymphoma cells apoptosis in vitro and in vivo.Exp Cell Res. 2019 Dec 1;385(1):111623. doi: 10.1016/j.yexcr.2019.111623. Epub 2019 Sep 19.
|
| 323 |
The extent of B-cell activation and dysfunction preceding lymphoma development in HIV-positive people.HIV Med. 2018 Feb;19(2):90-101. doi: 10.1111/hiv.12546. Epub 2017 Aug 31.
|
| 324 |
Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type.Clin Cancer Res. 2012 Aug 1;18(15):4183-90. doi: 10.1158/1078-0432.CCR-12-1064. Epub 2012 Jun 6.
|
| 325 |
Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical.Blood. 2007 Oct 1;110(7):2569-77. doi: 10.1182/blood-2006-12-062927. Epub 2007 Apr 17.
|
| 326 |
Efficacy of dose-adjusted EPOCH plus rituximab/R-CHOP regimens and the prognosis analysis in patients with MYC, BCL2/BCL6 gene copy number gain lymphoma and double-hit lymphoma: results from a single institution retrospective clinical study.Cancer Manag Res. 2019 Feb 11;11:1363-1372. doi: 10.2147/CMAR.S192143. eCollection 2019.
|
| 327 |
Modulation of the tumor microenvironment by intratumoral administration of IMO-2125, a novel TLR9 agonist, for cancer immunotherapy.Int J Oncol. 2018 Sep;53(3):1193-1203. doi: 10.3892/ijo.2018.4456. Epub 2018 Jun 27.
|
| 328 |
DIXDC1 promotes tumor proliferation and cell adhesion mediated drug resistance (CAM-DR) via enhancing p-Akt in Non-Hodgkin's lymphomas.Leuk Res. 2016 Nov;50:104-111. doi: 10.1016/j.leukres.2016.09.011. Epub 2016 Sep 8.
|
| 329 |
Dlx5 Homeodomain:DNA Complex: Structure, Binding and Effect of Mutations Related to Split Hand and Foot Malformation Syndrome.J Mol Biol. 2016 Mar 27;428(6):1130-1141. doi: 10.1016/j.jmb.2016.01.023. Epub 2016 Jan 29.
|
| 330 |
Serological identification of HSP105 as a novel non-Hodgkin lymphoma therapeutic target.Blood. 2011 Oct 20;118(16):4421-30. doi: 10.1182/blood-2011-06-364570. Epub 2011 Aug 22.
|
| 331 |
Integrated analysis of 10 lymphoma datasets identifies E2F8 as a key regulator in Burkitt's lymphoma and mantle cell lymphoma.Am J Transl Res. 2019 Jul 15;11(7):4382-4396. eCollection 2019.
|
| 332 |
Overexpression of the immediate-early genes Egr1, Egr2, and Egr3 in two strains of rodents susceptible to audiogenic seizures.Epilepsy Behav. 2017 Jun;71(Pt B):226-237. doi: 10.1016/j.yebeh.2015.12.020. Epub 2016 Jan 14.
|
| 333 |
Inhibiting CARD11 translation during BCR activation by targeting the eIF4A RNA helicase.Blood. 2014 Dec 11;124(25):3758-67. doi: 10.1182/blood-2014-07-589689. Epub 2014 Oct 15.
|
| 334 |
Expression and activity of eIF6 trigger malignant pleural mesothelioma growth in vivo.Oncotarget. 2015 Nov 10;6(35):37471-85. doi: 10.18632/oncotarget.5462.
|
| 335 |
The oncogenic role of the ETS transcription factors MEF and ERG.Cell Cycle. 2010 Sep 1;9(17):3457-9. doi: 10.4161/cc.9.17.13000. Epub 2010 Sep 13.
|
| 336 |
Rothmund-Thomson syndrome and osteoma cutis in a patient previously diagnosed as COPS syndrome.Eur J Pediatr. 2017 Feb;176(2):279-283. doi: 10.1007/s00431-016-2834-3. Epub 2016 Dec 30.
|
| 337 |
Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV-infected patient.Hematol Oncol. 2019 Apr;37(2):176-184. doi: 10.1002/hon.2562. Epub 2018 Nov 6.
|
| 338 |
Pipeline for large-scale microdroplet bisulfite PCR-based sequencing allows the tracking of hepitype evolution in tumors.PLoS One. 2011;6(7):e21332. doi: 10.1371/journal.pone.0021332. Epub 2011 Jul 5.
|
| 339 |
Angioimmunoblastic T-cell lymphoma and hypereosinophilic syndrome with FIP1L1/PDGFRA fusion gene effectively treated with imatinib: A case report.Medicine (Baltimore). 2017 Sep;96(36):e8001. doi: 10.1097/MD.0000000000008001.
|
| 340 |
The role of fibromodulin in cancer pathogenesis: implications for diagnosis and therapy.Cancer Cell Int. 2019 Jun 10;19:157. doi: 10.1186/s12935-019-0870-6. eCollection 2019.
|
| 341 |
FOXO4 expression is related to stem cell-like properties and resistance to treatment in diffuse large B-cell lymphoma.Oncotarget. 2017 Jan 10;8(2):2466-2476. doi: 10.18632/oncotarget.13690.
|
| 342 |
MicroRNA-376a regulates cell proliferation and apoptosis by targeting forkhead box protein P2 in lymphoma.Oncol Lett. 2018 Sep;16(3):3169-3176. doi: 10.3892/ol.2018.9012. Epub 2018 Jun 22.
|
| 343 |
miR-155 regulates HGAL expression and increases lymphoma cell motility.Blood. 2012 Jan 12;119(2):513-20. doi: 10.1182/blood-2011-08-370536. Epub 2011 Nov 16.
|
| 344 |
From cytopenia to leukemia: the role of Gfi1 and Gfi1b in blood formation.Blood. 2015 Dec 10;126(24):2561-9. doi: 10.1182/blood-2015-06-655043. Epub 2015 Oct 7.
|
| 345 |
Loss of signalling via G13 in germinal centre B-cell-derived lymphoma.Nature. 2014 Dec 11;516(7530):254-8. doi: 10.1038/nature13765. Epub 2014 Sep 28.
|
| 346 |
Acidosis decreases c-Myc oncogene expression in human lymphoma cells: a role for the proton-sensing G protein-coupled receptor TDAG8.Int J Mol Sci. 2013 Oct 11;14(10):20236-55. doi: 10.3390/ijms141020236.
|
| 347 |
Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints.Oncogene. 2009 Nov 12;28(45):3997-4008. doi: 10.1038/onc.2009.258. Epub 2009 Aug 31.
|
| 348 |
Epigenetic control via allosteric regulation of mammalian protein arginine methyltransferases.Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):10101-10106. doi: 10.1073/pnas.1706978114. Epub 2017 Sep 5.
|
| 349 |
Heterogeneous epigenetic regulation of HACE1 in Burkitt- Lymphoma-derived cells.Leuk Res. 2017 Sep;60:53-57. doi: 10.1016/j.leukres.2017.06.006. Epub 2017 Jun 16.
|
| 350 |
The TP53-Induced Glycolysis and Apoptosis Regulator mediates cooperation between HTLV-1 p30(II) and the retroviral oncoproteins Tax and HBZ and is highly expressed in an in vivo xenograft model of HTLV-1-induced lymphoma.Virology. 2018 Jul;520:39-58. doi: 10.1016/j.virol.2018.05.007. Epub 2018 May 26.
|
| 351 |
Adoptive transfer of murine T cells expressing a chimeric-PD1-Dap10 receptor as an immunotherapy for lymphoma.Immunology. 2017 Nov;152(3):472-483. doi: 10.1111/imm.12784. Epub 2017 Jul 27.
|
| 352 |
Polymorphism in the tumor necrosis factor-alpha promotor region and in the heat shock protein 70 genes associated with malignant tumors.Cancer. 1997 Oct 15;80(8):1489-96. doi: 10.1002/(sici)1097-0142(19971015)80:8<1489::aid-cncr17>3.0.co;2-1.
|
| 353 |
Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma.Blood. 2017 Jan 26;129(4):473-483. doi: 10.1182/blood-2016-07-729954. Epub 2016 Nov 14.
|
| 354 |
IBTK contributes to B-cell lymphomagenesis in E-myc transgenic mice conferring resistance to apoptosis.Cell Death Dis. 2019 Apr 11;10(4):320. doi: 10.1038/s41419-019-1557-6.
|
| 355 |
Interleukin-25 Axis Is Involved in the Pathogenesis of Human Primary and Experimental Murine Sjgren's Syndrome.Arthritis Rheumatol. 2018 Aug;70(8):1265-1275. doi: 10.1002/art.40500. Epub 2018 Jun 27.
|
| 356 |
Interleukin-9 promotes cell survival and drug resistance in diffuse large B-cell lymphoma.J Exp Clin Cancer Res. 2016 Jul 1;35(1):106. doi: 10.1186/s13046-016-0374-3.
|
| 357 |
Establishment and characterization of a novel VEGF-producing HHV-8-unrelated PEL-like lymphoma cell line, OGU1.Eur J Haematol. 2016 Feb;96(2):144-51. doi: 10.1111/ejh.12559. Epub 2015 Apr 21.
|
| 358 |
IRF4 promotes Epstein-Barr virus activation in Burkitt's lymphoma cells.J Gen Virol. 2019 May;100(5):851-862. doi: 10.1099/jgv.0.001249. Epub 2019 Mar 25.
|
| 359 |
Expression of interferon regulatory factor 7 correlates with the expression of Epstein-Barr Virus latent membrane protein 1 and cervical lymph node metastasis in nasopharyngeal cancer.Pathol Int. 2017 Sep;67(9):461-466. doi: 10.1111/pin.12561. Epub 2017 Jul 16.
|
| 360 |
An RNA Aptamer-Based Biomarker Platform Demonstrates High Soluble CD25 Occupancy by IL2 in the Serum of Follicular Lymphoma Patients.Cancer Immunol Res. 2019 Sep;7(9):1511-1522. doi: 10.1158/2326-6066.CIR-18-0821. Epub 2019 Aug 5.
|
| 361 |
ISL-1 is overexpressed in non-Hodgkin lymphoma and promotes lymphoma cell proliferation by forming a p-STAT3/p-c-Jun/ISL-1 complex.Mol Cancer. 2014 Jul 29;13:181. doi: 10.1186/1476-4598-13-181.
|
| 362 |
The ITM2B (BRI2) gene is a target of BCL6 repression: Implications for lymphomas and neurodegenerative diseases.Biochim Biophys Acta. 2015 May;1852(5):742-8. doi: 10.1016/j.bbadis.2014.12.018. Epub 2014 Dec 31.
|
| 363 |
Pro-apoptotic and antiproliferative activity of human KCNRG, a putative tumor suppressor in 13q14 region.Tumour Biol. 2010 Jan;31(1):33-45. doi: 10.1007/s13277-009-0005-0. Epub 2009 Dec 18.
|
| 364 |
Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases.PLoS One. 2015 Feb 20;10(2):e0117420. doi: 10.1371/journal.pone.0117420. eCollection 2015.
|
| 365 |
Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cells. Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14920-5. doi: 10.1073/pnas.0904231106. Epub 2009 Aug 12.
|
| 366 |
Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified.Haematologica. 2018 Apr;103(4):679-687. doi: 10.3324/haematol.2017.182444. Epub 2018 Jan 5.
|
| 367 |
Safety study of culinary-medicinal Royal Sun Agaricus, Agaricus brasiliensis S. Wasser et al. KA21 (higher Basidiomycetes) assessed by prokaryotic as well as eukaryotic systems.Int J Med Mushrooms. 2012;14(2):135-48. doi: 10.1615/intjmedmushr.v14.i2.20.
|
| 368 |
A gene panel, including LRP12, is frequently hypermethylated in major types of B-cell lymphoma.PLoS One. 2014 Sep 16;9(9):e104249. doi: 10.1371/journal.pone.0104249. eCollection 2014.
|
| 369 |
MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell Lymphomagenesis.Cancer Cell. 2018 Sep 10;34(3):453-465.e9. doi: 10.1016/j.ccell.2018.08.006.
|
| 370 |
Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes.Nat Commun. 2018 Aug 24;9(1):3417. doi: 10.1038/s41467-018-05979-8.
|
| 371 |
Mice deficient in MIM expression are predisposed to lymphomagenesis.Oncogene. 2012 Jul 26;31(30):3561-8. doi: 10.1038/onc.2011.509. Epub 2011 Nov 14.
|
| 372 |
An NKp30-based chimeric antigen receptor promotes T cell effector functions and antitumor efficacy in vivo.J Immunol. 2012 Sep 1;189(5):2290-9. doi: 10.4049/jimmunol.1103495. Epub 2012 Jul 30.
|
| 373 |
The B7 Family Member B7-H6: a New Bane of Tumor.Pathol Oncol Res. 2018 Oct;24(4):717-721. doi: 10.1007/s12253-017-0357-5. Epub 2017 Oct 31.
|
| 374 |
Nfe2l3 (Nrf3) deficiency predisposes mice to T-cell lymphoblastic lymphoma.Blood. 2011 Feb 10;117(6):2005-8. doi: 10.1182/blood-2010-02-271460. Epub 2010 Dec 8.
|
| 375 |
Small cell lung cancer mimicking lymphoma in CT and 68Ga-DOTA-NOC PET/CT: A case report.Medicine (Baltimore). 2018 Jun;97(25):e11159. doi: 10.1097/MD.0000000000011159.
|
| 376 |
Cyclic Cystine-Bridged Peptides from the Marine Sponge Clathria basilana Induce Apoptosis in Tumor Cells and Depolarize the Bacterial Cytoplasmic Membrane.J Nat Prod. 2017 Nov 22;80(11):2941-2952. doi: 10.1021/acs.jnatprod.7b00477. Epub 2017 Nov 2.
|
| 377 |
Expression of splice variants of cancer-testis genes ODF3 and ODF4 in the testis of a prostate cancer patient.Genet Mol Res. 2012 Oct 4;11(4):3642-8. doi: 10.4238/2012.October.4.11.
|
| 378 |
Collagen prolyl hydroxylase 3 has a tumor suppressive activity in human lung cancer.Exp Cell Res. 2018 Feb 1;363(1):121-128. doi: 10.1016/j.yexcr.2017.12.020. Epub 2017 Dec 23.
|
| 379 |
The JAK inhibitor antcin H exhibits direct anticancer activity while enhancing chemotherapy against LMP1-expressed lymphoma.Leuk Lymphoma. 2019 May;60(5):1193-1203. doi: 10.1080/10428194.2018.1512709. Epub 2018 Oct 2.
|
| 380 |
A Phase 1 Study to Assess the Relative Bioavailability of Two Capsule Formulations of Ixazomib, an Oral Proteasome Inhibitor, in Patients With Advanced Solid Tumors or Lymphoma.J Clin Pharmacol. 2018 Jan;58(1):114-121. doi: 10.1002/jcph.987. Epub 2017 Aug 7.
|
| 381 |
The prohibitin protein complex promotes mitochondrial stabilization and cell survival in hematologic malignancies.Oncotarget. 2017 Jul 1;8(39):65445-65456. doi: 10.18632/oncotarget.18920. eCollection 2017 Sep 12.
|
| 382 |
Reduced expression of the tumor suppressor PHLPP1 enhances the antiapoptotic B-cell receptor signal in chronic lymphocytic leukemia B-cells.Leukemia. 2010 Dec;24(12):2063-71. doi: 10.1038/leu.2010.201. Epub 2010 Sep 23.
|
| 383 |
Profiling the expression pattern of GPI transamidase complex subunits in human cancer.Mod Pathol. 2008 Aug;21(8):979-91. doi: 10.1038/modpathol.2008.76. Epub 2008 May 16.
|
| 384 |
Prep1 (pKnox1)-deficiency leads to spontaneous tumor development in mice and accelerates EmuMyc lymphomagenesis: a tumor suppressor role for Prep1.Mol Oncol. 2010 Apr;4(2):126-34. doi: 10.1016/j.molonc.2010.01.001. Epub 2010 Jan 7.
|
| 385 |
Silencing of CKIP-1 promotes tumor proliferation and cell adhesion-mediated drug resistance via regulating AKT activity in non-Hodgkin's lymphoma.Oncol Rep. 2017 Jan;37(1):622-630. doi: 10.3892/or.2016.5233. Epub 2016 Nov 8.
|
| 386 |
Female GADD34 mice develop age-related inflammation and hepatocellular carcinoma.Geriatr Gerontol Int. 2017 Dec;17(12):2593-2601. doi: 10.1111/ggi.13080. Epub 2017 Jun 21.
|
| 387 |
A Noncanonical Function of Polycomb Repressive Complexes Promotes Human Cytomegalovirus Lytic DNA Replication and Serves as a Novel Cellular Target for Antiviral Intervention.J Virol. 2019 Apr 17;93(9):e02143-18. doi: 10.1128/JVI.02143-18. Print 2019 May 1.
|
| 388 |
Spectrum of Atypical Clinical Presentations in Patients with Biallelic PRF1 Missense Mutations.Pediatr Blood Cancer. 2015 Dec;62(12):2094-100. doi: 10.1002/pbc.25646. Epub 2015 Jul 16.
|
| 389 |
IFR4/MUM1-positive lymphoma in Waldeyer ring with co-expression of CD5 and CD10.Pediatr Blood Cancer. 2017 Feb;64(2):311-314. doi: 10.1002/pbc.26236. Epub 2016 Sep 12.
|
| 390 |
CBP/p300 acetyltransferases regulate the expression of NKG2D ligands on tumor cells.Oncogene. 2017 Feb 16;36(7):933-941. doi: 10.1038/onc.2016.259. Epub 2016 Aug 1.
|
| 391 |
A Rapid Embryonic Stem Cell-Based Mouse Model for B-cell Lymphomas Driven by Epstein-Barr Virus Protein LMP1.Cancer Immunol Res. 2015 Jun;3(6):641-9. doi: 10.1158/2326-6066.CIR-15-0058. Epub 2015 May 1.
|
| 392 |
An RCOR1 loss-associated gene expression signature identifies a prognostically significant DLBCL subgroup.Blood. 2015 Feb 5;125(6):959-66. doi: 10.1182/blood-2013-06-507152. Epub 2014 Nov 13.
|
| 393 |
Influence of MTHFR and RFC1 polymorphisms on toxicities during maintenance chemotherapy for childhood acute lymphoblastic leukemia or lymphoma. J Pediatr Hematol Oncol. 2008 May;30(5):347-52.
|
| 394 |
Combined inhibition of PI3K-related DNA damage response kinases and mTORC1 induces apoptosis in MYC-driven B-cell lymphomas.Blood. 2013 Apr 11;121(15):2964-74. doi: 10.1182/blood-2012-08-446096. Epub 2013 Feb 12.
|
| 395 |
The role of a newly identified SET domain-containing protein, SETD3, in oncogenesis.Haematologica. 2013 May;98(5):739-43. doi: 10.3324/haematol.2012.066977. Epub 2012 Oct 12.
|
| 396 |
Novel mutations in ataxia telangiectasia and AOA2 associated with prolonged survival.J Neurol Sci. 2013 Dec 15;335(1-2):134-8. doi: 10.1016/j.jns.2013.09.014. Epub 2013 Sep 17.
|
| 397 |
CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolin.PLoS One. 2014 Dec 26;9(12):e115517. doi: 10.1371/journal.pone.0115517. eCollection 2014.
|
| 398 |
Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis.Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3111-6. doi: 10.1073/pnas.0910667107. Epub 2010 Feb 1.
|
| 399 |
Smarcal1 and Zranb3 Protect Replication Forks from Myc-Induced DNA Replication Stress.Cancer Res. 2019 Apr 1;79(7):1612-1623. doi: 10.1158/0008-5472.CAN-18-2705. Epub 2019 Jan 4.
|
| 400 |
Epigenetic regulator Smchd1 functions as a tumor suppressor.Cancer Res. 2013 Mar 1;73(5):1591-9. doi: 10.1158/0008-5472.CAN-12-3019. Epub 2012 Dec 26.
|
| 401 |
Cooperative STAT/NF-B signaling regulates lymphoma metabolic reprogramming and aberrant GOT2 expression.Nat Commun. 2018 Apr 17;9(1):1514. doi: 10.1038/s41467-018-03803-x.
|
| 402 |
Colorectal cancer DNA methylation marker panel validated with high performance in Non-Hodgkin lymphoma.Epigenetics. 2014 Mar;9(3):428-36. doi: 10.4161/epi.27554. Epub 2013 Dec 20.
|
| 403 |
SPIB is a novel prognostic factor in diffuse large B-cell lymphoma that mediates apoptosis via the PI3K-AKT pathway.Cancer Sci. 2016 Sep;107(9):1270-80. doi: 10.1111/cas.13001. Epub 2016 Sep 6.
|
| 404 |
STAT4, TRAF3IP2, IL10, and HCP5 Polymorphisms in Sjgren's Syndrome: Association with Disease Susceptibility and Clinical Aspects.J Immunol Res. 2019 Feb 10;2019:7682827. doi: 10.1155/2019/7682827. eCollection 2019.
|
| 405 |
Expression of SSX genes in human tumors.Int J Cancer. 1998 Jul 3;77(1):19-23. doi: 10.1002/(sici)1097-0215(19980703)77:1<19::aid-ijc4>3.0.co;2-2.
|
| 406 |
Signal transducer and activator of transcription (STAT)-5: an opportunity for drug development in oncohematology.Oncogene. 2019 Jun;38(24):4657-4668. doi: 10.1038/s41388-019-0752-3. Epub 2019 Feb 19.
|
| 407 |
Development of classical Hodgkin's lymphoma in an adult with biallelic STXBP2 mutations.Haematologica. 2013 May;98(5):760-4. doi: 10.3324/haematol.2012.073098. Epub 2012 Oct 25.
|
| 408 |
Silencing P2X7 receptor downregulates the expression of TCP-1 involved in lymphoma lymphatic metastasis.Oncotarget. 2015 Dec 8;6(39):42105-17. doi: 10.18632/oncotarget.5870.
|
| 409 |
Association between lymphoma prognosis and aberrant methylation of ID4 and ZO-1 in bone marrow and paraffin-embedded lymphoma tissues of treatment-naive patients.Oncol Rep. 2013 Jul;30(1):455-61. doi: 10.3892/or.2013.2450. Epub 2013 May 10.
|
| 410 |
Pro-death and pro-survival properties of ouabain in U937 lymphoma derived cells.J Exp Clin Cancer Res. 2012 Nov 15;31(1):95. doi: 10.1186/1756-9966-31-95.
|
| 411 |
Abnormal accumulation of human transmembrane (TMEM)-176A and 176B proteins is associated with cancer pathology.Acta Histochem. 2012 Nov;114(7):705-12. doi: 10.1016/j.acthis.2011.12.006. Epub 2012 Jan 12.
|
| 412 |
Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types.Int J Cancer. 2004 May 1;109(5):786-92. doi: 10.1002/ijc.20041.
|
| 413 |
Need for an improved molecular/genetic classification for CD30+ lymphomas involving the skin.Cancer Control. 2007 Apr;14(2):124-32. doi: 10.1177/107327480701400205.
|
| 414 |
The Upregulation of TRAF1 Induced by Helicobacter pylori Plays an Antiapoptotic Effect on the Infected Cells.Helicobacter. 2016 Dec;21(6):554-564. doi: 10.1111/hel.12311. Epub 2016 Apr 6.
|
| 415 |
Signaling mechanisms of bortezomib in TRAF3-deficient mouse B lymphoma and human multiple myeloma cells.Leuk Res. 2016 Feb;41:85-95. doi: 10.1016/j.leukres.2015.12.005. Epub 2015 Dec 19.
|
| 416 |
TREX1 variants in Sjogren's syndrome related lymphomagenesis.Cytokine. 2020 Aug;132:154781. doi: 10.1016/j.cyto.2019.154781. Epub 2019 Jul 18.
|
| 417 |
TRIM65 is a potential oncogenic protein via ERK1/2 on Jurkat and Raji cells: A therapeutic target in human lymphoma malignancies.Cell Biol Int. 2018 Nov;42(11):1503-1510. doi: 10.1002/cbin.11035. Epub 2018 Sep 11.
|
| 418 |
TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphoma.Blood. 2018 Jun 21;131(25):2789-2802. doi: 10.1182/blood-2017-09-806679. Epub 2018 Apr 13.
|
| 419 |
T-cell regulation by casitas B-lineage lymphoma (Cblb) is a critical failsafe against autoimmune disease due to autoimmune regulator (Aire) deficiency.Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14709-14. doi: 10.1073/pnas.1009209107. Epub 2010 Jul 28.
|
| 420 |
The SRC family kinase LYN redirects B cell receptor signaling in human SLP65-deficient B cell lymphoma cells.Oncogene. 2006 Aug 17;25(36):5056-62. doi: 10.1038/sj.onc.1209510. Epub 2006 Mar 27.
|
| 421 |
A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase-regulated mammalian target of rapamycin activation.Blood. 2009 May 21;113(21):5206-16. doi: 10.1182/blood-2008-09-179762. Epub 2009 Mar 25.
|
| 422 |
FcRL4(+) B-cells in salivary glands of primary Sjgren's syndrome patients.J Autoimmun. 2017 Jul;81:90-98. doi: 10.1016/j.jaut.2017.03.012. Epub 2017 Apr 6.
|
| 423 |
Gene expression profiling in lymphoma diagnosis and management.Best Pract Res Clin Haematol. 2009 Jun;22(2):191-210. doi: 10.1016/j.beha.2009.05.001.
|
| 424 |
Granulysin-mediated tumor rejection in transgenic mice.J Immunol. 2007 Jan 1;178(1):77-84. doi: 10.4049/jimmunol.178.1.77.
|
| 425 |
Overexpression of a transcription factor LYL1 induces T- and B-cell lymphoma in mice.Oncogene. 2007 Oct 18;26(48):6937-47. doi: 10.1038/sj.onc.1210494. Epub 2007 May 7.
|
| 426 |
Differential expression of the human MIXL1 gene product in non-Hodgkin and Hodgkin lymphomas.Hum Pathol. 2007 Mar;38(3):500-7. doi: 10.1016/j.humpath.2006.09.020.
|
| 427 |
Anaplastic plasmacytoma of mouse--establishing parallels between subtypes of mouse and human plasma cell neoplasia.J Pathol. 2010 Jul;221(3):242-7. doi: 10.1002/path.2714.
|
| 428 |
Defects of FA/BRCA pathway in lymphoma cell lines.Int J Hematol. 2008 Dec;88(5):543-550. doi: 10.1007/s12185-008-0199-8. Epub 2008 Nov 15.
|
| 429 |
The CALM and CALM/AF10 interactor CATS is a marker for proliferation.Mol Oncol. 2008 Dec;2(4):356-67. doi: 10.1016/j.molonc.2008.08.001. Epub 2008 Sep 4.
|
| 430 |
Gene amplification and associated loss of 5' regulatory sequences of CoAA in human cancers.Oncogene. 2007 Feb 8;26(6):822-35. doi: 10.1038/sj.onc.1209847. Epub 2006 Jul 31.
|
| 431 |
Ribosomal Protein Rpl22 Controls the Dissemination of T-cell Lymphoma.Cancer Res. 2016 Jun 1;76(11):3387-96. doi: 10.1158/0008-5472.CAN-15-2698. Epub 2016 Apr 5.
|
| 432 |
Molecular profiling of CD3-CD4+ T cells from patients with the lymphocytic variant of hypereosinophilic syndrome reveals targeting of growth control pathways.Blood. 2009 Oct 1;114(14):2969-83. doi: 10.1182/blood-2008-08-175091. Epub 2009 Jul 16.
|
| 433 |
Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas.Blood. 2008 Jan 1;111(1):351-8. doi: 10.1182/blood-2007-06-094151. Epub 2007 Sep 26.
|
|
|
|
|
|
|
